Generated by All in One SEO v4.9.1, this is an llms.txt file, used by LLMs to index the site.

# ADMAC ONCOLOGY

## Sitemaps

- [XML Sitemap](https://admaconcology.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [BLOG](https://admaconcology.com/blog/) - Read our blogs section to get updated related to cancer drugs, oncology products and so on. Visit now!
- [Researchers found new treatment to treat metastatic colorectal cancer](https://admaconcology.com/researchers-found-new-treatment-to-treat-metastatic-colorectal-cancer/) - A clinical trial found that adavosertib was effective to delay tumor growth in metastatic colorectal cancer patients. Read to know more!
- [BaP combination found effective to treat blood cancers](https://admaconcology.com/bap-combination-found-effective-to-treat-blood-cancers/) - A clinical trial found that adavosertib was effective to delay tumor growth in metastatic colorectal cancer patients. Read to know more!
- [Common Gynaecological Disorders That Women Face](https://admaconcology.com/common-gynaecological-disorders-that-women-face/) - Millions of women suffer from the gynaecological disorders listed above, but happily, there are a variety of therapies available for common gynaecological issues – and discovering them begins with a visit to a gynaecologist.
- [Bortezomib Represent a Valuable Therapy for Multiple Myeloma](https://admaconcology.com/bortezomib-therapy-for-multiple-myeloma/) - Bortezomib is the first approved proteasome inhibitor with significant efficacy for treatment of multiple myeloma. Learn about this drug in detail.Multiple myeloma is the second most common blood cancer and accounts for 154,000 cases and 101,000 deaths per year, worldwide. The global burden of multiple myeloma has been increasing uniformly for the last 30 years with varied prevalence rates among different countries. It is a type of blood cancer that is caused by excess production
- [Are you aware of colorectal cancer?](https://admaconcology.com/colorectal-cancer-and-preventive-ways/) - Colorectal cancer (CRC) is known to be the reason behind 10% global cancer deaths annually. However the incidence rates of CRC varied according to the geographical variations. More than half of CRC cases are found in developed countries, but the mortality rate is greater in less developed nations with insufficient health infrastructure and restricted resources.
- [Triple Negative Breast Cancer: Things you must need to know](https://admaconcology.com/triple-negative-breast-cancer/) - 'March 3 is Triple Negative Breast Cancer Day' Breast cancer is the second most frequently occurring pathology worldwide. Out of which triple negative breast cancer (TNBC) represents 10 to 15% of all identified breast cancer cases. This cancer type is far different from the other types of breast cancer. This is the reason the treatment
- [Pomegranate and citrus juice to prevent colorectal cancer](https://admaconcology.com/pomegranate-and-citrus-juice-to-prevent-colorectal-cancer/) - Colorectal cancer is considered to be the third leading cause behind cancer deaths globally. Also, the incidence of this cancer and associated mortality is still on rise, especially in developing countries. This is also known as colorectal adenocarcinoma. The treatment options for colorectal cancer varies from patient to patient and is assessed according to tumor
- [Know How Red Grapes are effective in Cancer Prevention](https://admaconcology.com/red-grapes-are-effective-in-cancer-prevention/) - Red grapes, Vitis vinifera is one of the most commonly lovable fruits around the world. It is both utilized as fresh table grapes or as processed fruit, in the form of raisins, wine, grape juice and molasses. Recently, this fruit has gained popularity due to one of its health benefits. It has been evaluated that
- [Exotic vegetables and fruits: The super anti-cancer foods](https://admaconcology.com/exotic-vegetables-and-fruits-anti-cancer-foods/) - The most challenging health concerns like diabetes, obesity and cancer are spreading wider and their treatment is an utmost challenge for healthcare professionals. Out of these, Cancer is one of the most common causes of death globally. Mortality rates from cancer are estimated to continue to emanate, with an estimation of 11.5 million deaths by
- [Abiraterone acetate for management of Prostate Cancer](https://admaconcology.com/abiraterone-acetate-for-management-of-prostate-cancer/) - Prostate cancer is the most common cancer and the second prominent cause of cancer-related deaths in men. As per the 2018 statistical data analysis, about 1,280,000 newly diagnosed cases of prostate cancer and 359,000 deaths were estimated around the globe. In India, about 25, 696 new cases and 17,184 deaths were estimated in 2018. Besides
- [Indian gooseberry to reduce cancer risk](https://admaconcology.com/indian-gooseberry-to-reduce-cancer-risk/) - Indian gooseberry or amla has a divine place in the Indian system of medicine, Ayurveda. The amla (Emblica Officinalis Gaertn) fruits are used in extensive ayurvedic preparations to improve the immunity against certain diseases. It is very beneficial in managing anemia, diabetes, liver problems, ulcers, heart troubles and cancer. Do You Know How Effective Indian
- [Hair Loss After Cancer Treatment: What You Need To Know](https://admaconcology.com/hair-loss-and-cancer-treatment/) - Hair loss or alopecia is a known side effect of various types of cancer treatment. It can take place as a side effect of chemotherapy, radiation therapy, stem cell transplant or targeted therapy. All these cancer treatments can harm the cells, which helps in hair growth. They can affect the hair of all parts of
- [Prevention measures to reduce Prostate Cancer Risk](https://admaconcology.com/prevention-measures-for-prostate-cancer-risk/) - Cancer prevention measures are taken to lower the risk of developing cancer. They help to lower the number of new cancer cases in the population. Eventually this can help to lower the number of deaths also. To prevent cancer it is very important to know the risk factors then only you can learn about the
- [Anemia in cancer patients: Are you aware?](https://admaconcology.com/anemia-in-cancer-patients/) - Anemia is a common problem among the cancer patients, with noticing negative impacts on overall prognosis and quality of life. The reasons are multifactorial, however the iron deficiency is the major cause and possibly the treatable contributor. Nutrition is found to be an important part of all the cancer association events, from reducing cancer risk
- [How to do breast self examination?](https://admaconcology.com/how-to-do-breast-self-examination/) - 'Breast cancer and cervix uteri are two most common cancers in Indian women', According to the Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. The burden of breast cancer is highest, especially in metropolitan cities. Undoubtedly, the chemotherapeutic treatments for breast cancer have significantly improved from the past. However, some of the women
- [Neem in diet: A healthy routine to reduce cancer risk](https://admaconcology.com/neem-in-diet-and-cancer-risk/) - If you were born and brought up in an Indian family, you might know the importance of neem trees. For many skin problems (acne, or itching), weak eyesight, unpurified blood, stomach ulcers and wounds, this herb has broad health benefits. Other than this, neem also known to have a potent anti-cancer effect. This herb helps
- [Do mobile phones actually cause brain tumors?](https://admaconcology.com/mobile-phones-and-brain-tumor/) - Mobile phones are becoming the necessity today. Almost every person on this planet uses this technology to connect with their friends, family and the whole world, But this amazing technology also comes with some side effects. 'The electromagnetic fields generated by the mobile phones can act as carcinogens' Cancer has become a life threatening problem.
- [Tulsi leaves to reduce cancer risk](https://admaconcology.com/tulsi-leaves-to-reduce-cancer-risk/) - Today, the advancements in technology and research have captivated everybody's attention towards complementary and alternative medicine (CAM) along with mainstream cancer therapies and treatments. From mind-body based interventions to alternative medical systems and biologically based therapies, CAM involved many effective modalities to reduce the cancer risk and mainstream treatment-associated side effects. One of these CAM
- [Keto diet: Prepare your body to fight off cancer](https://admaconcology.com/keto-diet-for-cancer/) - You definitely heard of various types of diets like intermittent fasting, paleo diet or Dash diets these days. People are adapting such diets for the long term to manage and treat a particular health problem. These diets help to control the problem of obesity, diabetes and many severe health problems like cancer. Plant-based foods, other
- [Guava: A potent anticancer fruit](https://admaconcology.com/guava-a-potent-anticancer-fruit/) - Guava (Psidium guajava) is one of the most loved tropical fruits by the people of India. This fruit grows in wild places or in commercial groves all over the subtropics and tropics. It comes in various shapes, colors and sizes. The fruit is not only consumed for its nutritional purpose but also for its medicinal
- [Association between plant-based diet and cancer prevention](https://admaconcology.com/association-between-plant-based-diet-and-cancer-prevention/) - There is no doubt that there is a connection between diet and cancer development. Healthy eating can reduce the risk of various cancers. Still, it is not possible to guarantee that following a particular diet will eliminate the risk of cancer development. However, many studies have proved that plant-based diet reduces the risk of many
- [The Cancer Prevention Properties of Allium Vegetables](https://admaconcology.com/allium-egetables/) - The history of taking medicinal plants traced back to ancient times. These medicinal herbs used to get relief from pain, various other ailments and also emotional distress. Out of these, allium genus vegetables have been extensively utilized in improving various health problems due to their health benefits. This class of vegetables is renowned for its
- [Liver cancer: Understand the causes, symptoms and treatment](https://admaconcology.com/liver-cancer-understand-the-causes-symptoms-and-treatment/) - The liver is indispensable for good health and is also susceptible to a variety of ailments. One such disease is liver cancer. Read on to learn more.
- [Exercise helps to battle prostate cancer, research says!](https://admaconcology.com/exercise-helps-to-battle-prostate-cancer-research-says/) - Research suggests that peptides released while exercising can significantly reduce the growth of tumours in prostate cancer patients. Learn more!
- [Efficacy and safety of anastrozole for the treatment of estrogen-positive breast cancer](https://admaconcology.com/efficacy-and-safety-of-anastrozole-for-the-treatment-of-estrogen-positive-breast-cancer/) - Breast cancer is one of the most common cancers among women caused due to longer exposure toowards estrogen. So anastrozole is a potent drug to cure it.
- [Role of curcumin for cancer prevention and treatment](https://admaconcology.com/role-of-curcumin-for-cancer-prevention-and-treatment/) - Curcumin is an anti cancer agent - inhibitor of angiogenesis, improves chemosensitization & so on. Therefore, a potential against various cancer cells.
- [Anticancer vitamins: Essential adjuvants to nutrition therapy](https://admaconcology.com/anticancer-vitamins-essential-adjuvants-to-nutrition-therapy/) - Today cancer has become a major health concern with increasing mortality levels each year. Researchers developed various effective strategies to prevent, manage and treat this deadly disease. Pattern oncological treatments like surgery, chemotherapy and radiotherapy have led to significant improvements in cancer prevention. However, scientists still seek to develop more innovative therapies which can improve
- [Diet for cancer patients: Do cruciferous vegetables fight against stomach cancer?](https://admaconcology.com/cancer-patient-diet/) - It is said that cruciferous vegetables plays a significant role in maintaining healthy stomach and this also affects the incidence of stomach cancer. Let's explore, how essential is to include the cruciferous vegetables in the diet for cancer patients: In the last few decades the mortality rate due to cancer is rising throughout the world
- [5 mandatory lifestyle modifications for cancer patients to be adopted after-treatment](https://admaconcology.com/lifestyle-modifications-for-cancer-patients-after-treatment/) - According to WHO, "Health is a state of complete physical, social and mental well-being and not merely the absence of disease or infirmity." Good health demands a healthy lifestyle, which involves nutritious food, healthy weight, physically active and stress-free life. A healthy lifestyle improves the quality of life of cancer survivors. The after-treatment lifestyle changes
- [Acronyms used to represent chemotherapy combinations: PART 1 (A to E)](https://admaconcology.com/acronyms-for-chemotherapy/) - The introduction and success of combination chemotherapy for treating various cancers has elicited the ever-growing complexity of cancer treatment regimens. Today, multidrug combinations with complex dosing parameters and sequencing have become normal. As a result, a nonformal jargon of acronyms emerged to ease the communication amongst patients and oncologists. This jargon can be a mix
- [Cancer preventing spices: Essential food for cancer patients](https://admaconcology.com/cancer-preventing-spices/) - Doctors and scientists these days stress on shifting to a healthy lifestyle, which involves active life and nutritious food. It not only prevents you from day to day health problems but also protects your body cells from being converted into cancerous cells. Cancer is one of the major reasons behind various deaths in the world
- [Top 11 foods to avoid to prevent cancer](https://admaconcology.com/foods-to-avoid-to-prevent-cancer/) - We all know food is essential for keeping the overall body healthy and fit. Healthy food habits keep our body free from toxins, free radicals, nutrient deprivation, and certain diseases. On the other hand, unhealthy foods can cause adverse effects. Along with a sedentary lifestyle, eating unhealthy can cost you certain types of metabolic or
- [Lycopene: A great cancer-fighting food component](https://admaconcology.com/lycopene-food-for-cancer/) - In today's era, cancer is one of the leading health concerns around the globe. More than 100 different types of cancer and tumours have put the millions life at stake. Out of various underlying reasons, oxidative stress is a significant cause of the development and progression of cancer. The oxidative damage can cause neoplasia (unrestricted
- [Benefits of Honey for Cancer Patients](https://admaconcology.com/benefits-of-honey-for-cancer-patients/) - Depicted by Stone Age painting, the use of honey by humans is traced back to around 8000 years ago. Honey is a renowned natural palatable sweetener that extensively used in cooking and baking. However, honey is also used in the field of medicine since ancient times due to its health-enhancing and medicinal properties. These properties
- [Top 6 Benefits of Yoga for Cancer Patients](https://admaconcology.com/yoga-for-cancer-patients/) - Yoga is an eminent ancient Indian practice that helps to attain mental, spiritual, moral, and physical well-being of an individual.Yoga comprises a well ordered 8-fold path named Astanga Yoga. According to the ancient scriptures of India, every step of yoga affects different aspects of health. Yoga for overall health: Being associated with numerous hemodynamic and
- [Artificial sweeteners: Good or Bad for cancer patients?](https://admaconcology.com/artificial-sweeteners-good-or-bad-for-cancer-patients/) - Food choices exert a significant effect on life. Healthy eating habits can keep our body fit and enhances longevity, whereas, unhealthy eating habits cause adverse effects. This rule is also applicable in controlling cancer progression. Food choices can exert a significant impact on the efficacy of various cancer treatments and therapies. One of the major
- [Dried Fruits: The quintessential food for cancer patients](https://admaconcology.com/dried-food-for-cancer-patients/) - Chemoprevention is a measure which involves the use of nontoxic synthetic and natural substances or their combinations to intercede the comparatively early stages of carcinogenesis, before the manifestations of invasive features. The natural or synthetic substances can be any chemotherapeutic drug, food, vitamins, or any other agent. One of these agents that can exert a
- [Apples: The best anti-cancer food with other health benefits](https://admaconcology.com/apple-anti-cancer-food/) - Fruits are always considered as salubrious food items, and higher fruit intake is significantly associated with reduced risk of disease-specific complications and all-cause mortality. According to a joint report by the American Institute for Cancer Research and the World Cancer Research Fund, the diet enriched with fruits and vegetables also associated with the significant reduction
- [Ginger: One of the best cancer-fighting foods](https://admaconcology.com/ginger-cancer-fighting-food/) - Worldwide, GI (Gastrointestinal) cancer is one of the most frequent cancers posing a burden on patients and the healthcare system. One of the best cancer fighting foods is ginger that has many valuable benefits to offer for prevention and reduction of cancerous cells. According to recent research, ginger may help to prevent cancer. It is
- [Ellagic acid: Cancer-fighting food ingredient](https://admaconcology.com/ellagic-acid-cancer-fighting-food/) - Worldwide, cancer is a major cause of death. In recent years, numerous plant-derived compounds have gained attention as alternative cancer remedies for improving the prevention and treatment of cancer. Ellagic acid is one such natural compound. Lets discuss the following in depth: What is ellagic acid? Sources of ellagic Acid Benefits of ellagic acid How
- [Importance of Okra for Cancer Patients](https://admaconcology.com/okra-for-cancer-patients/) - Cancer is a major health problem characterized by rampant abnormal cell growth and dissemination. There are approximately 10 million cases of cancer found annually across the whole world. The cancers came into existence due to several genetic defects as consequences of the infectious agent, wrong dietary habits, and exposure to the environment. "Nutritional factors including
- [Anticancer vitamins: Efficacy of vitamin C in beating back cancer](https://admaconcology.com/anticancer-vitamins/) - Vitamin C has been in the research and analysis field since the 1970s as a potential treatment for various cancers and gained attention in the management of malignancies in humans. Many of you must be aware of its detoxifying and skin rejuvenating properties, but its anticancer properties are also one of the major characteristics like
- [Rosemary: a complementary and alternative therapy in cancer prevention](https://admaconcology.com/rosemary-for-cancer-prevention/) - Nature not only presents us the life-sustaining air and water but also numerous bioactive molecules with significant roles in many diseases, including cancer. Today, cancer is one of the major causes of mortality around the world. "Presently, around 10 million new cases are diagnosed every year throughout the world, and can rise to 20 million
- [Quercetin: Cancer-fighting food ingredient](https://admaconcology.com/quercetin-cancer-fighting-food-ingredient/) - In humans, cancer is a life-threatening malignancy. Worldwide, cancer is the second leading cause of death posing a substantial burden globally. Nowadays, natural products are becoming a topic of research for drug discovery. High dietary consumption of fruits and vegetables has been found to reduce the risk of cancer. Among natural compounds, quercetin has been
- [Role of Geniposide in cancer management](https://admaconcology.com/geniposide-for-cancer-management/) - Globally, cancer has emerged as a leading health concern. It is estimated that the number of new cancer cases can elevate by 70% over the next two decades. For decades, medicinal plants have been constantly exploited by mankind as sources of cancer-fighting agents. There is an emerging focus on the identification and production of novel
- [Importance of Cardamom for Cancer Management](https://admaconcology.com/cardamom-for-cancer-management/) - “Let food be thy medicine and medicine be thy food – Hippocrates” Indeed, nutrition and health are intimately linked. Cancer, a life-threatening malignancy, is the leading cause of morbidity and mortality. It is a significant healthcare concern in both developed and developing countries. The rising cost of conventional cancer therapy and the subsequent unpleasant effects have
- [Berberine for cancer management](https://admaconcology.com/berberine-for-cancer-management/) - Globally, cancer is a leading public health problem. The mortality rate due to cancer is rising throughout the world at an exponential rate. Thus, the development of robust strategies to mitigate cancer is essential. Plants are one of the richest sources of natural compounds and continue to provide novel remedies to mankind. Natural products from
- [Anticancer flavonoid wogonin for cancer treatment](https://admaconcology.com/anticancer-flavonoid-wogonin-for-cancer-treatment/) - Worldwide, cancer has created havoc and has posed a substantial burden on patients and the healthcare system. To combat cancer, numerous treatments such as chemotherapy, radiation therapy, surgery, targeted therapy, and immunotherapy are used. However, these current chemotherapeutics are linked with unpleasant side effects and drug resistance. It is essential to identify alternative cancer treatments
- [Evaluation of Resveratrol as an anti-cancer food](https://admaconcology.com/resveratrol-anti-cancer-food/) - Natural active components in the present day are considered as one of the most potent sources in drug development. Isolated from various sources, especially from plants and their parts, these natural components significantly helps in treating or managing various ailments. Cancer is one of them. Till date, many studies have evaluated the efficacy of certain
- [Fisetin: A dietary plant pigment for cancer prevention & treatment](https://admaconcology.com/fisetin-for-cancer-prevention/) - Healthy lifestyle, home remedies and cost-effective phytomedicines are the beneficial modalities that are considered to be the first-employed preventive measure or treatment for many health problems such as obesity, diabetes, arthritis, and certain cancers. Phytomedicines are the reliable and potential method of prevention and treatment as it involves bio-actives like quercetin, fisetin, lycopene, geniposide that
- [Soluble and insoluble fibers: The potent anti cancer foods](https://admaconcology.com/soluble-and-insoluble-fibers-cancer/) - In healthy eating, dietary fibers are regarded as essential food nutrients. The prominence of fibers has increased up to the mark and the huge and potential market has been established on a larger level for fiber-rich products in recent years. Also, supplementation has been utilized to improve the fiber content of various foods. All of
- [Super anti-cancer foods you need to know](https://admaconcology.com/super-anti-cancer-foods/) - The disease management pays considerable attention to dispensing effective health modalities, resulting in a significant decrease in disability and mortality but at the expense of high and traumatic usage of medications, irradiation and surgeries, especially when talking about cancer therapy and management. After cardiovascular disorders, cancer is considered as the second principal cause of death
- [Top 5 Foods to Prevent Cancer](https://admaconcology.com/foods-to-prevent-cancer/) - Your body is the reflection what you generally eat. Healthy eating reflects a salubrious, fit and strong body and immune system. On the other hand, fried, junk and oily food make your body fatty, obese and full of cardiovascular, metabolic and many more disorders. Today, one of the major disease following cardiovascular problems is cancer.
- [Anti cancer fruits categories that can lower your cancer risk](https://admaconcology.com/anti-cancer-fruits/) - As evident from research studies, Nutrition plays a major role in cancer. According to the estimates of American Institute for Cancer Research and the World Cancer Research Fund, about 30-40% cancers can be prevented by physical activity, appropriate diet and maintenance of body diet. Filling up your diet plate with anti cancer fruits rich in
- [Berries: Potent Anti-Cancer Fruit](https://admaconcology.com/berries-anti-cancer-fruit/) - Cancer is a global health problem with high mortality rates. Eating a balanced diet that includes foods rich in vitamins, minerals and antioxidants is vital. Making healthy lifestyle choices, staying active, and maintaining a healthy weight can go a long way in combating your risk for cancer. Consumption of anti-cancer fruits and vegetables has been
- [Obesity and cancer: How deleterious is the relationship?](https://admaconcology.com/obesity-and-cancer/) - Overweight and obesity have become one of the major health concern all around the world due to the dramatic elevation in its prevalence. The existing impact of this disease has turned out to be the major risk factor behind several health concerns, such as hypertension, type-2 diabetes, stroke, Arthritis and several types of cancer. It
- [Deleterious effects of Ultraviolet radiation on the incidence of skin cancer](https://admaconcology.com/uv-rays-and-skin-cancer/) - Being part of the 16% of body mass, the skin is considered to be the largest organ of the body, and one major protective barrier of the body as well. Skin not only plays a significant role in resistance to infectious pathogens, chemicals agents, sun (UV and IR) rays but also, participate in the various
- [Olive oil: A potent natural oil to prevent Colorectal Cancer](https://admaconcology.com/olive-oil-to-prevent-clorectal-cancer/) - Colorectal cancer (also known as colorectal adenocarcinoma) is the fourth cause of cancer-related mortality and the third most common cancer worldwide. The incidence of this deadly cancer is steadily rising. Notably, dietary habits are thought to contribute to about 50% of cases of colorectal cancer. Therefore, following a healthy and nutritious diet could primarily prevent
- [African leafy vegetables and their influence on cancer prevention](https://admaconcology.com/african-leafy-vegetables-and-cancer-prevention/) - Talking about cancer causing factors, somatic and environmental factors are two of the major causes. Diet adds about 35% of the entire somatic and environmental causes. There are many foods that plays a significant role in cancer prevention and in slowing down the progression of cancerous cell lines. In these, there are many vegetables that
- [Exercise: A vital cancer prevention strategy](https://admaconcology.com/exercise-a-vital-cancer-prevention-strategy/) - Worldwide, more than 10 million individuals are diagnosed with cancer. According to International Agency for Research on Cancer (IARC), 25% of cancer cases are due to obesity, overweight, and a sedentary lifestyle. In the rehabilitation of oncological patients, physical exercise has attracted widespread attention. In research studies exploring the impact of exercise in cancer patients,
- [Naturally occurring antioxidants and cancer prevention](https://admaconcology.com/antioxidants-for-cancer-prevention/) - Free radicals and the antioxidant concept has been extensively studied and evaluated in the recent year due to its major role in regulating proper body's physiological functions. The capability of deploying oxygen has given humans the advantage of metabolizing carbohydrates, fats and proteins for energy. However, this action can also prove to be harmful in
- [Environmental Carcinogens and Cancer Progression: A harmful association](https://admaconcology.com/association-between-environmental-carcinogens-and-cancer-progression/) - Talking about environmental carcinogens, it involves all the indoor and outdoor air pollutants along with drinking water and soil contaminants. The association between environmental pollution and human health is very disturbing as the pollutants may lead to substantial health concerns, specifically to those body parts which extremely exposed to these hazard components. These pollutants can
- [Clove: A valuable spice effective for cancer prevention](https://admaconcology.com/clove-effective-for-cancer-prevention/) - Cancer is emerging as the foremost health problem globally. Every year, the number of cancer patients just keep escalating at a terrifying rate. Also, there has been a rising resistance towards anticancer drugs, which worsens the efficacy and future of cancer management. Further, due to the treatment associated deleterious side effects, the current approach for
- [Black Cumin: A Food Additive With Potent Chemoprotective Properties](https://admaconcology.com/black-cumin-role-in-cancer-prevention/) - Herbal medicine is one of the ancient and widespread therapeutic options for healing health-related problems. Over the centuries, people around the world have been utilizing several medicinal herbs to mitigate the signs and symptoms of certain diseases. It is quite enthralling that regardless of huge achievements in conventional medicine and therapeutics. The herbal formulations are
- [3 Best Seeds to Consume for Cancer Prevention](https://admaconcology.com/best-seeds-for-cancer-prevention/) - As per the research, the diet has always been significant in cancer prevention. The foods we take in our diet are considered to be the essential source of potent physiologically functional constituents. It is also noticed from the various pieces of scientific pieces of evidence that a healthy diet for cancer patients show strong correlations
- [Anastrozole: An effective drug to treat Breast Cancer](https://admaconcology.com/anastrozole-drug-to-treat-breast-cancer/) - Currently, breast cancer is recognized as one of the largest epidemiological problems in females. This invasive cancer affects about 2.1 million females each year and is the principal cause of cancer-associated mortality among females. Estrogen, a primary female sex hormone, plays a fundamental role in the growth and progression of hormone-dependent tumours of the breast.
- [Erdafitinib: A Promising Targeted Therapy For Bladder Cancer](https://admaconcology.com/erdafitinib-therapy-for-bladder-cancer/) - Bladder cancer, also renowned with the name of urinary bladder cancer or urological cancer, is considered amongst the world's most common cancers and the incidences of this problematic cancer are still on the rise steadily, notably in developed countries. According to the latest GLOBOCAN data, bladder cancer is accounting for about 3% of the global
- [Nutritional Seeds for Cancer Prevention](https://admaconcology.com/nutritional-seeds-for-cancer-prevention/) - Maintain a healthy lifestyle and healthy weight: These are the most prior aspects to keep body hale and hearty. It helps to reduce your risk of getting certain types of health problems, like, heart disease, diabetes, high blood pressure, digestive problems and even certain types of cancer. Presently, there are about 10 million new cases
- [Male Breast Cancer: Symptoms, Causes & Treatments](https://admaconcology.com/male-breast-cancer/) - Breast cancer is the second most common cancer worldwide. In males, this cancer is considered as the non-negligible cause of cancer deaths. Over the last few decades, people are more aware of factors associated with increasing risk of breast cancer. Also, potential treatments have been evaluated and approved over the time to treat this cancer.
- [Natural antioxidants in preventing skin cancer](https://admaconcology.com/natural-antioxidants-prevents-skin-cancer/) - In the present scenario, skin cancer incidences have risen exponentially. It is counted in the most common cancers worldwide, ranking second in females and first in males. One of the major risk factors behind this is the constant and intense exposure of skin to the reactive species and oxidative stress arising from endogenous and exogenous
- [Cancer Protective Properties of Tannic Acids](https://admaconcology.com/tannic-acids/) - Cancer is a condition in which some body cells start to divide uncontrollably and spread into nearby tissues. It can begin in any part of the body that can involve trillions of cells. The damaged and old cells continue to exist and new cells arise without need. The extra cells divide nonstop to form tumors.
- [Garden pea in Cancer Prevention](https://admaconcology.com/garden-pea/) - Cancer is one of the chief causes of death globally. But researchers have proposed that it can be prevented up to 30-50% with the assistance of easy lifestyle modifications, such as eating healthy, doing regular exercise, maintaining the right body weight and quitting smoking. Nutrition especially is believed to help in cancer prevention up to
- [Breast cancer: Effective cancer preventive tips to consider](https://admaconcology.com/breast-cancer-preventive-tips/) - Breast cancer incidences are rising in the developing world. It is the most common type of cancer that occurs in women. Most forms of this cancer are invasive. There are various types of invasive breast cancer. The two most common forms are invasive ductal carcinoma in situ dcis and invasive lobular carcinoma in situ. There
- [Natural ways to prevent liver cancer](https://admaconcology.com/ways-to-prevent-liver-cancer/) - Liver cancer is counted amongst the most common types of the digestive system associated cancers. Out of this, primary liver cancer is the six most frequently diagnosed cancer and fourth principal cause of cancer mortality around the globe. It is estimated 841,000 cases of liver cancer and 782,000 deaths in 2018 Talking about managing this
- [Coffee: A Brewed Drink to Reduce the risk of Liver Cancer](https://admaconcology.com/coffee-for-liver-cancer/) - Coffee drinkers have a special place for coffee. They cannot imagine a day without this drink. It is one of the most popular brewed drinks around the world. Around one-third, the world's population consumes this. It is consumed for its stimulating and refreshing effect. Human society has been using coffee beans since the past 1200
- [Serious effects of Smoking in increasing Lung Cancer Risk](https://admaconcology.com/smoking-and-lung-cancer-risk/) - Every organ in our body performs its own function to keep it working and fit. Most of the time people are not able to observe the problems with their organs such as lungs in daily life as they are able to breathe without any difficulty. But damage to these important organs can lead to severe
- [Influence of Vegetable and Fruits Color on Colorectal Cancer](https://admaconcology.com/vegetable-and-fruits-color-on-colorectal-cancer/) - In the prevention and lowering the various types of cancers, vegetables and fruits play a very essential role. Not only in preventing cancer, but also in preventing other health problems like heart problems, diabetes, mental illnesses, obesity and digestive problems. A healthy and nutritious diet has always been a part of a healthy lifestyle. The
- [Is bitter almond effective in cancer prevention?](https://admaconcology.com/bitter-almond-and-cancer-prevention/) - Almonds are considered as a potent healthy food supplement and are in great demand in the general population around the world. The reason behind its popularity is the health benefits, this nut provides to human community. Being rich in lipids (50%), proteins (25%) and carbohydrates (20%) this nut is amazing keeping health in a salubrious
- [Important considerations for cancer in COVID-19 times](https://admaconcology.com/cancer-and-covid-19/) - Cancer patients always face higher risk of getting infections. Many cancers modify the working of our immune system. In many cases, the treatment of cancer affects the defense mechanism of the body. Even in the cancer survivor, the immune system may not be able to fight germs. In some cases the cancers can affect the
- [Diabetes and Cancer Prevention](https://admaconcology.com/diabetes-and-cancer-prevention/) - Cancer and diabetes are counted among the common diseases that have a huge impact on health around the world. It is also evident from various epidemiologic studies that these two diseases are interlinked. People with diabetes are found to have a higher risk for many types of cancer. It is considered to be one of
- [An association between Alcohol consumption and Cancer](https://admaconcology.com/alcohol-consumption-and-cancer/) - Extreme alcohol drinking in any way is injurious to health. It is said that drinking in moderate amounts can be beneficial for cardiovascular health. Moderation alcohol drinking defined as no more than 3 drinks a day for males (maximum 15 a week) and 2 drinks a day for females (maximum 10 a week). This amount
- [PCOS and cancer: a possible harmful association](https://admaconcology.com/pcos-and-cancer/) - Polycystic ovary syndrome (PCOS) is a gynecological problem, which influences 1 in 10 females of childbearing age. It is the most common endocrinopathy in reproductive females with an estimated incidence of around 10 percent. Females with PCOS maybe characterized bymenstrualirregularity, a polycystic morphology of the ovary, and hyperandrogenism. “As per to PCOS Foundation, solely 50%
- [Cancer Prevention Properties of Pomegranate](https://admaconcology.com/cancer-prevention-properties-of-pomegranate/) - Cancer is considered as the second leading cause of death worldwide. It has been assessed that by 2030 the incidence of new cancer will rise by 70% around the world due to only demographic changes. Commonly, cancer is known as a disease of genetic origin. However, research over the past various decades has acclaimed that
- [Efficacy of periwinkle in cancer prevention](https://admaconcology.com/periwinkle-and-cancer-prevention/) - Periwinkle or Madagascar periwinkle, a perennial herb with beautiful flowers has a significant place in health care. Scientifically, it is known as Catharanthus roseus. In India, this plant is renowned with the name of Sada bahar, Ainskati, Sadaphul, Nayantara, Ushamanjairi and Nithyakalyani. The medicinal and therapeutic properties of this plant is due to its alkaloids.
- [Are red and processed meat cancer risk factors?](https://admaconcology.com/processed-meat-and-cancer-risk-factors/) - Cancer is the second most significant cause of morbidity and mortality in developing countries. It changes globally and is liable to vary with modifications in lifestyle and dietary factors. It has been concluded through the research that the high fat diet is a significant cancer risk factor. It is linked with augmented vulnerability to develop
- [Association between Blue Light and the Development of Uveal Melanoma](https://admaconcology.com/association-between-blue-light-and-uveal-melanoma/) - Uveal melanoma (UM) is the second most common major tumour of the eye globally after childhood retinoblastoma and is the primary fatal intraocular disorder in adults. UM occurs in melanocytes found within the three different regions of the uveal tract: choroid, iris and ciliary body. It can be diagnosed at any age. However, it is
- [Future of precious & valuable spice as Anti Cancer Agent](https://admaconcology.com/future-of-precious-valuable-spice-as-anti-cancer-agent/) - The research and treatment in oncology have always been a great area of interest. The reason behind this is the major impact of this deadly disorder on life expectancy and the quality of life. In the past decade, major advances have been seen in the management of cancer. These days plant derivatives and natural products
- [Anti-cancer foods: Lemon & lemon products](https://admaconcology.com/anti-cancer-food-lemon/) - Citrus fruits are one of the highly-valued fruits with potential medicinal and therapeutic value. In traditional Asian medicinal systems as well this fruit has a significant space. Evident from various analyses, it has been evaluated that nutritional consumption of lemon and associated products exhibited an inverse association with certain infectious ailments and cancers. Diet always
- [Do hormones increase cancer risk?](https://admaconcology.com/hormones-increase-cancer-risk/) - Hormones have an immense power. They have a major role in the functioning of your body. They control your growth, food processing, and even the working of your immune system. Hormones can influence your body weight, body temperature and even mood. Well, they can even have an effect on your cancer risk. Most of the
- [Association between HelicoBacter Pylori and Gastric Cancer](https://admaconcology.com/association-between-helicobacter-pylori-and-gastric-cancer/) - Helicobacter pylori is a gastric pathogen. Infection with H. pylori causes chronic inflammation and considerably raises the risk of gastric and duodenal ulcer disease and gastric cancer. Infection with H. pylori is a well known risk factor for the development of gastric cancer.Gastric cancer is the second major cause of cancer-related deaths globally. Once H.
- [Kimchi: Fermented Korean cuisine for cancer prevention](https://admaconcology.com/kimchi-fermented-korean-cuisine-for-cancer-prevention/) - The death rate due to cancer has been rising all over the world. Early diagnosis and treatment with lesser side effects or no side effects and great efficacy always remains the first priority of the scientists. Today, there are a number of treatments of cancers that used to halt and terminate various cancer cell lines.
- [Link between Cancer and Immunity](https://admaconcology.com/cancer-and-immunity/) - Every second there is a battle going on between the good and evil inside our body. The good is our immune system, with cells as the army to defend the body from infection and illness. The evil can be the germ and mutated cells which can cause harm to the body. When it comes to
- [Ways to reduce the risk of Stomach Cancer](https://admaconcology.com/aays-to-reduce-the-risk-of-stomach-cancer/) - Stomach cancer develops when the abnormal cells grow out of control in any of the three linings of the stomach. There are various types of cancer that can develop in the stomach. Cancer generally starts in the inner layer and spreads into the outer layers. It can spread to nearby organs or to distant parts
- [Heart problems arising due to Cancer Treatment](https://admaconcology.com/heart-problems-due-to-cancer-treatment/) - Cancer treatments- Radiation therapy and chemotherapy are raising the number of people who survive cancer. Though, they can also cause various health issues, including cardiovascular disease. The heart conditions are the side effects, which develop after cancer treatments are upsetting. Heart muscles start becoming weak soon after the beginning of chemotherapy with some chemotherapy agents.
- [Mediterranean diet: Healthy eating for cancer prevention](https://admaconcology.com/mediterranean-diet-for-cancer-prevention/) - People are now focused on being healthy and fit. Especially after the pandemic that jolted every single person deep down. It provides us with a lesson about how important our health is for us. The best way to provide your body with a whole required nutrition is being physically active and adopting good eating habits
- [Cancer symptoms to be taken seriously by women](https://admaconcology.com/cancer-symptoms-to-be-taken-seriously-by-women/) - Life is a beautiful journey that should be enjoyed by living healthy and staying fit. It should never be taken for granted when the incidence of getting diseases is increasing especially the incidence of cancer in women. The prevention and treatment of many of life threatening cancers is possible if they are found at early
- [Repeatedly heated cooking oils can increase cancer risk](https://admaconcology.com/repeatedly-heated-cooking-oils-and-cancer/) - There are many cancer risks which might be hidden from our bare eyes. For instance, constant exposure to harmful sun rays, pollution, smoking, chronic health problems and foods like processed and red meats. Cooking oil is also one of them. Undoubtedly, vegetable or cooking oils are the major part of our Indian lives. These oils
- [What should be the daily protein requirement during cancer?](https://admaconcology.com/daily-protein-requirement-during-cancer/) - For a healthy weight, good strength, immunity, and healthy body tissues, nutrition therapy plays an important role in the life of cancer patients. Cancer may change the way the body utilizes nutrients. Inadequate nutrition or malnutrition can restrict the response of cancer patients towards their associated chemotherapy or other treatments. Some of the cancer treatments
- [Cancer during the pregnancy: What do you need to know?](https://admaconcology.com/cancer-during-the-pregnancy/) - Cancer during pregnancy is rare. However, it will be more complex to diagnose and treat if it develops during pregnancy. This is because cancer diagnosis and treatments can affect the fetus. The prevalence of cancer in pregnancy is likely to increase as women delay childbirth until their later years. The tumours such as cervical cancer,
- [Green Tea: A healthy infusion for cancer prevention](https://admaconcology.com/green-tea-for-cancer-prevention/) - Benefits of green tea are immense. It helps to lower bad cholesterol, high blood pressure, high blood sugar and reduces the risk of heart diseases. But tea drinkers might don’t know one other benefit of green tea. In recent years, another possible association has been seen between green tea and cancer prevention. Hirota Fujiki and
- [Cancer risk related to Food color additives](https://admaconcology.com/cancer-risk-related-to-food-color-additives/) - Food color additives are the major part of our lifestyle. Many are used to provide different colors tints to your fruit punch, or red/green color to your toothpaste. Color additives are natural pigments, dyes and other substances that give color to food or any other item when added to them. But, are they safe? Do
- [Whole grains: A food to reduce breast cancer risk](https://admaconcology.com/whole-grains-to-reduce-breast-cancer-risk/) - Breast cancer is the most common cancer diagnosed in females globally and has become the growing global health problem over the last few decades. In North America and Europe, this cancer is more prevalent as compared to the Asian countries. One of the major reasons behind this fact is the difference in dietary habits and
- [10 Most Common Breast Cancer Myths Busted](https://admaconcology.com/10-most-common-breast-cancer-myths-busted/) - Myths related to breast cancer are many but you must act wisely and try to search for facts. Read the breast cancer myths buster series by ADMAC Oncology.
- [Prostate Cancer: 6 Common Myths vs Facts](https://admaconcology.com/prostate-cancer-6-common-myths-vs-facts/) - Many prostate cancer myths are around but focus on facts presented by ADMAC Oncology to avoid misconceptions and unnecessary stress related to prostate cancer.
- [Colon cancer: Foods to eat and avoid](https://admaconcology.com/colon-cancer-foods-to-eat-and-avoid/) - Colon cancer patients should stay hydrated and eat a well-balanced diet rich in vitamins, minerals, fibres, proteins, healthy fats, and antioxidants.
- [Prevailing 8 myths about ovarian cancer you should get rid of](https://admaconcology.com/prevailing-8-myths-about-ovarian-cancer-you-should-get-rid-of/) - Ovarian cysts don't equate to ovarian cancer. Pap and CA-125 tests are not reliable. Talcum powder doesn’t cause and HPV vaccine doesn’t prevent ovarian cancer.
- [Chemotherapy myths: Is there any truth behind these common beliefs?](https://admaconcology.com/chemotherapy-myths-is-there-any-truth-behind-these-common-beliefs/) - Chemotherapy is not always painful. It doesn't always cause hair loss. It is just half the truth. Learn the facts associated with common chemotherapy myths.
- [Malignant vs Benign Tumor: Know the Differences](https://admaconcology.com/malignant-vs-benign-tumor-know-the-differences/) - Compared to benign tumours, malignant tumours are life-threatening and may reoccur after removal. They proliferate rapidly and spread to distant areas.
- [6 Tips to Follow for Healthy Living after Cancer in Pandemic](https://admaconcology.com/6-tips-to-follow-for-healthy-living-after-cancer-in-pandemic/) - Simple healthcare tips can improve well being and quality of life of cancer survivors in the COVID-19 pandemic. Find out what you can do to stay healthy.
- [Eye Cancer: What you need to know?](https://admaconcology.com/eye-cancer-what-you-need-to-know/) - Eye cancer is rare cancer that may not be something you commonly hear about. Learn in-depth about eye cancer, its symptoms, risk factors and treatment.
- [9 Common skin Cancer Myths you should aware of](https://admaconcology.com/9-common-skin-cancer-myths-you-should-aware-of/) - Skin cancer sometimes becomes hard to diagnose due to some of the very common myths. Look at these myths and protect your skin from being malignant.
- [What are Neuroendocrine Tumors and should I be concerned?](https://admaconcology.com/what-are-neuroendocrine-tumors-and-should-i-be-concerned/) - Neuroendocrine tumors are the abnormal growth of neuroendocrine cells, which further also leads to abnormal development of hormones, which can be really fatal.
- [Occult primary cancer: A truly hidden metastatic cancer](https://admaconcology.com/occult-primary-cancer-a-truly-hidden-metastatic-cancer/) - Occult primary cancer is a metastatic cancer, whose primary site of origin cannot be evaluated. Find more about this unknown cancer and it affects on body.
- [Top 6 medicinal mushrooms for cancer prevention](https://admaconcology.com/top-6-medicinal-mushrooms-for-cancer-prevention/) - Medicinal mushrooms are under appreciated food but are you aware of their health benefits such as cancer prevention. Explore their anticancer benefits.
- [Nutrition in cancer: How to nourish your body against illness?](https://admaconcology.com/nutrition-in-cancer-how-to-nourish-your-body-against-illness/) - Proper nutrition in cancer is essential to maintain a healthy weight, improve adherence to the treatment, and recover faster.
- [Cognitive impairment in cancer patients! Are you aware?](https://admaconcology.com/cognitive-impairment-in-cancer-patients-are-you-aware/) - Cancer Related Cognitive Impairment ‘Chemo brain’ is a terminology that refers to cognitive impairment that happens during or after cancer or cancer treatment.
- [Nutrition guide for neuroendocrine tumour patients](https://admaconcology.com/nutrition-guide-for-neuroendocrine-tumour-patients/) - Patients with a neuroendocrine tumour should restrict amines, lactose, fried, oily, high salt, sugar and alcohol in their diet and adopt healthy eating habits.
- [Pregnancy after breast cancer- Things to refocus!](https://admaconcology.com/pregnancy-after-breast-cancer-things-to-refocus/) - Pregnancy after breast cancer treatment is safe but you need to consider some things. Here’s when to conceive and what to avoid for a safe pregnancy.
- [Complementary therapies for reducing pain in cancer patients](https://admaconcology.com/complementary-therapies-for-reducing-pain-in-cancer-patients/) - Complementary therapies and palliative treatment of cancer can be effective as they may improve associated symptoms and mental and physical well-being.
- [Cancer fatigue: What you need to know!](https://admaconcology.com/cancer-fatigue-what-you-need-to-know/) - Cancer-related fatigue is not like general fatigue. You have to take care of associated risk factors, lifestyle and dietary changes to cope with it.
- [5 risk factors that put you at high risk of tongue cancer](https://admaconcology.com/5-risk-factors-that-put-you-at-high-risk-of-tongue-cancer/) - Tobacco, HPV infection, smoking betel nut, these are some of the major concerning risk factors that can increase the risk of tongue cancer.
- [How to manage neutropenia following cancer treatment?](https://admaconcology.com/how-to-manage-neutropenia-following-cancer-treatment/) - Neutropenia is a condition of reduced white blood cell count in cancer patients, especially those undergoing chemotherapy.
- [Why is early detection essential for cancer prevention?](https://admaconcology.com/why-is-early-detection-essential-for-cancer-prevention/) - Early screening helps people to detect the hidden malignant tumors and cancerous cells on time. This helps to start treatment on time and improves the patient's quality of life.
- [5 things you need to know about bone cancer (a rare sarcoma)](https://admaconcology.com/5-things-you-need-to-know-about-bone-cancer-a-rare-sarcoma/) - July is Sarcoma Awareness Month, so educate yourself this July about this rare sarcoma to stay protected. Read more for detailed information!
- [Colonoscopy: A valuable screening tool for colorectal cancer](https://admaconcology.com/colonoscopy-a-valuable-screening-tool-for-colorectal-cancer/) - Colonoscopy helps to diagnose colorectal cancer and precancerous polyps, and investigate intestinal signs and symptoms.
- [Cancer Cachexia: Causes, Symptoms, Diagnosis and Treatment](https://admaconcology.com/cancer-cachexia-causes-symptoms-diagnosis-and-treatment/) - Being diagnosed with cancer is bad news, but tackling these hard core disorders becomes even more difficult when patients face the risk of being afflicted with an illness that adversely affects your appetite and body mass, eventually leading to death. One such fatal illness is ‘Cachexia’ or ‘Wasting syndrome’. It is a multifactorial syndrome leading
- [5 tips for managing mouth sores in cancer patients](https://admaconcology.com/5-tips-for-managing-mouth-sores-in-cancer-patients/) - Mouth sores are common among cancer patients. If you are dealing with mouth sores, you are not alone. Read more to get some relief.
- [Mammography: A life-saving diagnostic tool for breast cancer](https://admaconcology.com/mammography-a-life-saving-diagnostic-tool-for-breast-cancer/) - Mammography helps to screen and diagnose breast cancer in women and should begin at the age of 40 years. Read in detail about this technique.
- [Skin cancer: All you need to know!](https://admaconcology.com/skin-cancer-all-you-need-to-know/) - Skin cancer is majorly caused by harmful UV rays and can be prevented. Read about its major signs, risk factors and preventive measures in detail.
- [5 Strategies to manage cancer related depression](https://admaconcology.com/5-strategies-to-manage-cancer-related-depression/) - People with cancer may experience depression during and after treatment. Learn more about cancer-related depression and how it can be treated here.
- [Lung cancer: Types, Risk factors and How to prevent it!](https://admaconcology.com/lung-cancer-types-risk-factors-and-how-to-prevent-it/) - Do you know what types of lung cancer there are? Are you more likely to get lung cancer if you are a smoker? How will you prevent it? Read in detail here.
- [Dark chocolate: A delicious anti cancer food to try](https://admaconcology.com/dark-chocolate-a-delicious-anti-cancer-food-to-try/) - Dark chocolates contain cancer-fighting antioxidants called flavanols that defend against harmful free radicals and thus help in cancer prevention.
- [Tips to manage insomnia when you have cancer!](https://admaconcology.com/tips-to-manage-insomnia-when-you-have-cancer/) - Are you having trouble sleeping, after cancer treatment? If yes, then you may have insomnia. Read in detail about insomnia and tips to manage it.
- [Is cancer hereditary or acquired? Know the truth.](https://admaconcology.com/is-cancer-hereditary-or-acquired-know-the-truth/) - Is cancer a hereditary disorder? Learn how gene mutations can be inherited and passed on to children and what can be done to reduce the risk of cancer
- [What Every Woman Should Know About Uterine Cancer](https://admaconcology.com/what-every-woman-should-know-about-uterine-cancer/) - Abnormal vaginal bleeding, pelvic pain, pain during urination and/or sex, unpleasant and foul-smelling discharge are early warning signs of uterine cancer.
- [HPV infection: A well-established cause of certain cancers](https://admaconcology.com/hpv-infection-a-well-established-cause-of-certain-cancers/) - It's true. HPV infections can increase your risk of getting cancer. Learn more about HPV infection and how it is related to the risk of cancer.
- [Diagnostic Tests for Prostate Cancer: What you want to know?](https://admaconcology.com/diagnostic-tests-for-prostate-cancer-what-you-want-to-know/) - Prostate cancer can be tested by digital rectal exam, prostate-specific antigen blood test, biopsy, imaging tests and genetic testing. Know in detail here.
- [Are Hair dyes carcinogenic or safe to use? Read more to know](https://admaconcology.com/are-hair-dyes-carcinogenic-or-safe-to-use-read-more-to-know/) - Worried dyes can lead you to a cancerous path? Researchers have some evidence regarding whether dyes are carcinogenic or not. To know, read the article.
- [Basics of a disease that kills silently: ‘Pancreatic Cancer’](https://admaconcology.com/basics-of-a-disease-that-kills-silently-pancreatic-cancer/) - Pancreatic disease is a deadly disease which is often diagnosed in advanced stages. Learn all the basics of pancreatic cancer to reduce its risk.
- [Healthy Fats: Top Cancer Fighting Foods You Should Know](https://admaconcology.com/healthy-fats-top-cancer-fighting-foods-you-should-know/) - Omega 3 fats, monounsaturated fats, and conjugated linoleic acids are the top three healthy fats that can help to fight cancer. Read to know more.
- [Childhood cancers: All you need to know!](https://admaconcology.com/childhood-cancers-all-you-need-to-know/) - Understanding the symptoms and types of childhood cancers can help in its prevention. Read to know!
- [Jackfruit: A potential anti-cancer fruit for cancer prevention](https://admaconcology.com/jackfruit-a-potential-anti-cancer-fruit-for-cancer-prevention/) - Jackfruit is an exotic anti-cancer fruit which has multiple health benefits. Do you know? It can also help with cancer prevention. Explore more!
- [Metastatic Breast Cancer Awareness Day: What you should know?](https://admaconcology.com/metastatic-breast-cancer-awareness-day-what-you-should-know/) - October 13 marks metastatic breast cancer awareness day. Let's learn about this deadly cancer in detail on this day.
- [CAR T cell therapy- Reprogramming T cells to fight cancer](https://admaconcology.com/car-t-cell-therapy-reprogramming-t-cells-to-fight-cancer/) - Chimeric antigen receptor (CAR) T-cell therapy is a novel therapy that uses a patient's T cells to target cancer cells. Learn more about this therapy in detail.
- [Tisotumab vedotin approved by FDA to treat cervical cancer](https://admaconcology.com/tisotumab-vedotin-approved-by-fda-to-treat-cervical-cancer/) - Tisotumab vedotin is an tissue factor-directed antibody, recently approved by FDA for cervical cancer. Lean more about its efficacy and safety.
- [FDA approves Tazemetostat for Treating Follicular Lymphoma](https://admaconcology.com/tazverik-treating-follicular-lymphoma/) - On 18 June 2020, tazemetostat, an EZH2 (Enhancer of zeste homolog 2) inhibitor, procured U.S. FDA (United States Food and Drug Administration) accelerated approval to manage adult individuals with relapsed or refractory FL (follicular lymphoma) whose tumors are harboring an EZH2 mutation as identified by an FDA-approved test and who have been administered at least
- [Selinexor received FDA-approval to treat relapsed/refractory diffuse large B-cell lymphoma](https://admaconcology.com/xpovio-received-fda-approval/) - On June 22, 2020, selinexor received accelerated approval by the FDA (Food and Drug Administration) for management of relapsed/refractory DLBCL (diffuse large B-cell lymphoma). The drug's intended use is for adult individuals having relapsed/refractory DLBCL, not otherwise specified, including DLBCL emerging from follicular lymphoma, after receiving at least two lines of systemic therapy. A multicenter,
- [Lymphedema in cancer patients: How to manage and prevent it?](https://admaconcology.com/lymphedema-in-cancer-patients-how-to-manage-and-prevent-it/) - Lymphedema is a condition of damaged lymph nodes, causing swelling. In cancer patients, this condition can be problematic. Read here to know more.
- [Apatinib found effective to treat elderly patients with gastric cancer](https://admaconcology.com/apatinib-found-effective-to-treat-elderly-patients-with-gastric-cancer/) - Apatinib was found to be an effective therapeutic agent with good tolerability for elderly patients with unresectable advanced or metastatic gastric cancer.
- [Gemcitabine + ramucirumab effective for pleural mesothelioma](https://admaconcology.com/gemcitabine-ramucirumab-effective-for-pleural-mesothelioma/) - A combination of gemcitabine and ramucirumab can be a safe and effective treatment for pleural mesothelioma. Know more!
- [Efficacy of Ixa-Dara-dex in weak patients with myeloma revealed!](https://admaconcology.com/efficacy-of-ixa-dara-dex-in-weak-patients-with-myeloma-revealed/) - This Ixa-Dara-dex trial can serve as a platform for the upcoming design of trials for frail patients with multiple myeloma. Read more to know!
- [Immunotherapy: Medical achievement in the history of cancer](https://admaconcology.com/immunotherapy-medical-achievement-in-the-history-of-cancer/) - Immunotherapy is a medical achievement in the field of cancer. Learn more to know about it and how it helps to treat cancer.
- [Study: CAPTEM therapy found safe for neuroendocrine tumours](https://admaconcology.com/study-captem-therapy-found-safe-for-neuroendocrine-tumours/) - Combination of capecitabine and temozolomide therapy can be safe and effective in patients with neuroendocrine tumors.
- [Rywn can now be used for lymphoblastic leukemia and lymphoma](https://admaconcology.com/rywn-can-now-be-used-for-lymphoblastic-leukemia-and-lymphoma/) - Recombinant Asparaginase Erwinia Chrysanthemi can now be used as a component of treatment regimen used in common childhood cancer (leukemia)
- [FDA approved dostarlimab for dMMR solid tumors](https://admaconcology.com/fda-approved-dostarlimab-for-dmmr-solid-tumors/) - Dostarlimab has been granted FDA accelerated approval to treat patients with mismatch repair deficient (dMMR) advanced or recurrent solid tumors.
- [Gem/Cis/nab-P chemotherapy effective and safe to treat biliary tract cancer](https://admaconcology.com/gem-cis-nab-p-chemotherapy-effective-and-safe-to-treat-biliary-tract-cancer/) - A retrospective analysis found nab-paclitaxel plus gemcitabine-cisplatin to be effective and safe to manage patients with advanced biliary tract cancer.
- [FDA approves crizotinib to treat pediatrics and young adults with anaplastic large cell lymphoma](https://admaconcology.com/fda-approves-crizotinib-to-treat-pediatrics-and-young-adults-with-alcl/) - On 14 January 2021, crizotinib received Food and Drug Administration (FDA) approval for pediatrics one year of age and older and young individuals suffering from refractory or relapsed, systemic anaplastic large cell lymphoma (ALCL) that is anaplastic lymphoma kinase (ALK)-positive. ALCL is one of the morphologic variants of diffuse large B cell lymphoma (DLBCL). Crizotinib's
- [Biweekly cabazitaxel is safe to treat metastatic castration-resistant prostate cancer after docetaxel therapy](https://admaconcology.com/biweekly-cabazitaxel-is-safe-to-treat-metastatic-castration-resistant-prostate-cancer-after-docetaxel-therapy/) - A study published in the journal "Anticancer Research” stated that biweekly cabazitaxel results in clinically significant benefits and is a well-tolerated even after docetaxel for heavily pretreated metastatic castration-resistant prostate cancer (CRPC) patients. Pirkko-Liisa Kellokumpu-Lehtinen et al. undertook this study (Final Analysis of the Prosty II Trial) to explore the safety of a biweekly treatment
- [Ramucirumab plus erlotinib receives FDA approval to treat metastatic NSCLC](https://admaconcology.com/ramucirumab-plus-erlotinib-receives-fda-approval-to-treat-metastatic-nsclc/) - On 29 May 2020, the combination of erlotinib and ramucirumab received Food and Drug Administration (FDA) acceptance for managing metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 21 (L858R) substitution or exon 19 deletion mutations. A randomized, multicentre, double-blind, placebo-controlled, multinational analysis (RELAY) was performed to investigate the efficacy of
- [Neoadjuvant chemotherapy plus radical surgery is safe to treat cervical squamous cell carcinoma](https://admaconcology.com/neoadjuvant-chemotherapy-plus-radical-surgery-is-safe-to-treat-cervical-squamous-cell-carcinoma/) - Neoadjuvant chemotherapy followed by radical surgery is safe, feasible and exhibits low toxic adverse effects in cervical squamous cell carcinoma patients.
- [New cancer immunotherapy to treat HER2+ breast cancer patient](https://admaconcology.com/new-cancer-immunotherapy-to-treat-her2-breast-cancer-patient/) - Combining trastuzumab with magrolimab can be helpful in terminating HER2+ breast cancer cells and repressing trastuzumab tolerance.
- [Novel therapy for treating ALK-positive NSCLC developed!](https://admaconcology.com/novel-therapy-for-treating-alk-positive-nsclc-developed/) - Brigatinib gets FDA approval for treating (ALK)-positive metastatic non-small cell lung cancer (NSCLC) in adult patients with no prior treatment history.
- [Novel FDA-approved immunotherapy for Basal Cell Carcinoma](https://admaconcology.com/novel-fda-approved-immunotherapy-for-basal-cell-carcinoma/) - Cemiplimab-rwlc is novel immunotherapy approved by FDA to treat unruly advanced and metastatic basal cell carcinoma.
- [KRAS mutated NSCLC, possible to treat with Sotorasib](https://admaconcology.com/kras-mutated-nsclc-possible-to-treat-with-sotorasib/) - Sotorasib is the first new targeted therapy approved by the FDA to treat the unruly KRAS G12C mutated metastatic or locally advanced NSCLC.
- [Addition of Bevacizumab to standard chemotherapy beyond progression improves survival outcomes in ovarian cancer.](https://admaconcology.com/addition-of-bevacizumab-to-standard-chemotherapy-beyond-progression-improves-survival-outcomes-in-ovarian-cancer/) - A recent study published in "The Lancet Oncology" reported that compared with carboplatin-based doublet (standard chemotherapy) alone, treatment with carboplatin-based double plus bevacizumab beyond disease progression substantially improves progression-free survival in ovarian cancer patients. Investigators undertook this study to determine the benefit of continuing bevacizumab beyond progression after the first-line therapy with the same drug
- [Pembrolizumab receives FDA accelerated approval to treat HER2-positive gastric cancer](https://admaconcology.com/pembrolizumab-receives-fda-accelerated-approval-to-treat-her2-positive-gastric-cancer/) - On 5th May 2021, (US-FDA) granted its approval to pembrolizumab in combo with trastuzumab, platinum & fluoropyrimidine-containing chemotherapy
- [Lenalidomide found to improve progression-free survival in mantle cell lymphoma](https://admaconcology.com/lenalidomide-found-to-improve-progression-free-survival-in-mantle-cell-lymphoma/) - “The Lancet Haematology” depicted that lenalidomide after autologous haematopoetic stem-cell transplantation improves progression-free survival
- [Cabozantinib Plus Docetaxel and Prednisone found effective to treat Prostate Cancer](https://admaconcology.com/cabozantinib-plus-docetaxel-and-prednisone-found-for-prostate-cancer/) - The study published in “BJU International” indicated that the addition of cabozantinib to docetaxel/prednisone is safe with possible improved efficacy.
- [Sacituzumab Govitecan Significantly Prolongs Progression-free and Overall Survival in Breast Cancer Patients](https://admaconcology.com/sacituzumab-govitecan-for-breast-cancer-patients/) - In patients suffering from metastatic triple-negative breast cancer, progression-free & overall survival is substantially longer with sacituzumab govitecan.
- [How to manage Hypertension Related to Cancer Treatment?](https://admaconcology.com/ways-to-manage-hypertension-related-to-cancer-treatment/) - Right medication, exercise, healthy diet, and reducing stress, caffeine, smoking, drinking, salt intake can help to reduce hypertension in cancer patients.
- [Types of Blood Cancer: Leukemia, Lymphoma, Myeloma: What’s the difference?](https://admaconcology.com/types-of-blood-cancer/) - Blood cancer is a diverse group of disorders that occur when the blood cells multiply in an uncontrolled way and become cancerous.
- [Esophageal Cancer: Symptoms, Risk Factors, and Prevention](https://admaconcology.com/esophageal-cancer-symptoms-and-prevention/) - Presenting the risk factors, causes and prevention measures for esophageal cancer risk. Know these and follow some lifestyle changes to prevent the risk. Esophageal cancer, a devastating ailment affecting an individual’s esophagus, is on the rise! Worldwide, cancer of the esophagus is the eighth most common cancer and the sixth leading cause of death. It remains a significant public health problem. Understanding signs and symptoms, and preventing the occurrence of this deadly cancer affecting the gastrointestinal tract is
- [Kaempferol: Promising Anti-Cancer Compound present in your Diet](https://admaconcology.com/kaempferol-an-anti-cancer-compound/) - With antioxidant, anti-inflammatory, and anti-proliferative properties, kaempferol appears to have immense potential to combat different types of cancer.
- [Right treatment sequence of Abiraterone Acetate-Prednisone and Enzalutamide for Prostate Cancer](https://admaconcology.com/abiraterone-acetate-prednisone-and-enzalutamide-for-prostate-cancer/) - A study demonstrated clinical efficacy of abiraterone acetate plus prednisone followed by enzalutamide in delaying disease advancement. Read more.
- [10 Ways to Prevent Oral Cancer Risk](https://admaconcology.com/ways-to-prevent-oral-cancer-risk/) - Ten tips that can prevent the oral cancer risk includes no smoking or drinking, healthy diet, exercise, oral hygiene, HPV vaccination can prevent oral cancer.
- [Brain Tumor: What are the various risk factors?](https://admaconcology.com/various-risk-factors-for-brain-tumor/) - Factors like smoking, radiations, head injury, family history can raise brain cancer risk & can be reduced by avoiding smoking, exposure to carcinogenic chemicals & more.
- [FDA Grants Approval to Sacituzumab Govitecan to treat Triple-Negative Breast Cancer](https://admaconcology.com/fda-approves-sacituzumab-govitecan-for-triple-negative-breast-cancer/) - In April, Sacituzumab Govitecan was given approval for individuals suffering from mTNBC who were administered at least two previous therapies for metastatic cancer.
- [Top 12 Natural Remedies to Prevent Colorectal Cancer](https://admaconcology.com/remedies-to-prevent-colorectal-cancer/) - Colorectal cancer can be managed by eating healthy food, avoiding smoking and drinking, exercising, and keeping your weight in the ideal range.Colorectal cancer or colorectal tumor is the third most common type of cancer and the fourth most common cause of cancer-related death worldwide. As per the Indian Council of Medical Research, the annual incidence rates for colon tumor and rectal tumor in men are 4.4 and 4.1 per 100000, respectively while the annual incidence rates
- [Reduce the risk of bladder tumor: Lifestyle modifications](https://admaconcology.com/reduce-the-risk-of-bladder-tumor-lifestyle-modifications/) - Bladder cancer/tumor can be prevented by exercising regularly, eating a healthy diet, drinking enough water, and incorporating other lifestyle modifications.Following a healthy lifestyle is essential as it can help you to improve your longevity and reduce the risk some fatal diseases like cancer. One should always go for the nutritious plant food to prevent the risk of cancer as healthy plant-based diet can help to prevent cancer risk. There can be specific lifestyle modifications
- [Axicabtagene ciloleucel receives FDA approval to treat follicular lymphoma](https://admaconcology.com/axicabtagene-ciloleucel-receives-fda-approval-to-treat-follicular-lymphoma/) - On 5 March 2021, axicabtagene ciloleucel received accelerated approval by the USFDA to treat adults suffering from relapsed or refractory follicular lymphoma (non-Hodgkin's lymphoma). The approval was given on the basis of the findings from the ZUMA-5 trial, a multicenter, single-arm, open-label trial that investigated axicabtagene ciloleucel, a CD19-directed chimeric antigen receptor T cell therapy,
- [Low-dose pemetrexed need to be administered cautiously in patients with renal insufficiency](https://admaconcology.com/low-dose-pemetrexed-need-to-be-administered-cautiously-in-patients-with-renal-insufficiency/) - Pemetrexed is an effective & well-tolerated drug for lung cancer. Its monotherapy with reduced doses might be a safe treatment among patients with renal insufficiency.
- [Tivozanib receives FDA approval to treat advanced renal cell carcinoma](https://admaconcology.com/tivozanib-receives-fda-approval-to-treat-advanced-renal-cell-carcinoma/) - As per the notification on 10 March 2021, tivozanib received Food and Drug Administration (FDA) approval for the treatment of adult patients suffering from relapsed or refractory advanced renal cell carcinoma. This randomized, multicenter, open-label trial of tivozanib versus sorafenib (TIVO-3) investigated the efficacy of tivozanib (a kinase inhibitor) in individuals having advanced kidney cancer,
- [11 Superfoods that can reduce Lung Cancer Risk](https://admaconcology.com/superfoods-that-can-reduce-lung-cancer-risk/) - Incorporating apple, onions, ginger, garlic, soy foods, green tea, fish, cruciferous and green leafy vegetables, tomatoes, and selenium-rich foods can protect you from lung cancer.Lung cancer also known as lung tumor is the second most common cancer and the leading cause of cancer deaths in the world, among both males and females. According to the report from the National Cancer Registry Programme, about 1 in 68 males will develop lung cancer during their lifetime. Upto 80% of lung tumors
- [Poziotinib found to be valuable to treat mutated NSCLC](https://admaconcology.com/poziotinib-found-to-be-valuable-to-treat-mutated-nsclc/) - According to the findings presented at the European Society for Medical Oncology (ESMO) Targeted Anticancer Therapies Virtual Congress 2021, individuals suffering from epidermal growth factor receptor (EGFR) exon 20 mutant metastatic non-small cell lung cancer (NSCLC) displayed clinically meaningful benefit following treatment with poziotinib (a potent, irreversible, tyrosine kinase inhibitor). Investigators presented the efficacy data
- [EMA extends Durvalumab's Therapeutic Indications](https://admaconcology.com/ema-extends-durvalumabs-therapeutic-indications/) - The European Medicines Agency (EMA's) Committee for Medicinal Products for Human Use (CHMP) suggested an alteration to the terms of the marketing authorization for the medicinal product durvalumab on 23 July 2020. An extension to the existing therapeutic indication was adopted by CHMP as follows: As monotherapy, durvalumab is indicated for managing locally advanced, unresectable
- [Nivolumab vs. Sorafenib for the treatment of advanced hepatocellular carcinoma](https://admaconcology.com/nivolumab-vs-sorafenib-for-the-treatment-of-advanced-hepatocellular-carcinoma/) - At the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2020 Virtual (1-4 July), the long-term findings from the CheckMate 459 phase III study in Spain concluded that for the management of advanced hepatocellular carcinoma (HCC), nivolumab as a first-line treatment did not show statistically longer overall survival (OS) at a minimum
- [Pembrolizumab Receives FDA Approval to Treat TMB-H Tumors](https://admaconcology.com/pembrolizumab-receives-fda-approval-to-treat-tmb-h-tumors/) - For treating adult and pediatric patients having metastatic or unresectable tumor mutational burden-high (TMB-H) [defined as ≥10 mutations/megabase (mut/Mb)] solid tumors, as authenticated by a Food and Drug Administration (FDA)-approved test, that have advanced following prior treatment and who have no adequate alternatives, pembrolizumab received FDA approval on 16 June 2020. The FoundationOneCDx assay was
- [Pembrolizumab combinations therapy for mCRPC](https://admaconcology.com/pembrolizumab-combinations-therapy-for-mcrpc/) - For metastatic castration-resistant prostate cancer (mCRPC) patients, three combination therapies having pembrolizumab offered anti-tumour activity. In a study, the safety and effectiveness of pembrolizumab combination therapy were found in three groups of patients divided as per the pretreatment. In this study, patients in all the three groups were given pembrolizumab 200 mg intravenously every three
- [Novel Guidelines for Treating Advanced Prostate Cancer](https://admaconcology.com/novel-guidelines-for-treating-advanced-prostate-cancer/) - For managing patients with advanced prostate cancer, novel recommendations for clinicians have been released. To aid physicians to manage advanced prostate cancer (PCa), a novel guideline has been issued by the joint effort of three major medical organizations, the ASTRO (American Society for Radiation Oncology), AUA (American Urological Association), and SUO (Society of Urologic Oncology).
- [Subcutaneous bortezomib has become the standard of care in multiple myeloma](https://admaconcology.com/subcutaneous-bortezomib-standard-care-for-multiple-myeloma/) - According to the results of a recent systematic review and meta-analysis, subcutaneous (SC) administration of bortezomib can be regarded as a standard of care in the treatment of multiple myeloma (MM). Today, about 154,000 active cases and 101,000 deaths are owing to MM throughout the world every year. Bortezomib, an emerging first-in-class proteasome inhibitor is
- [FDA approves PHESGO to treat HER2-positive breast cancer](https://admaconcology.com/phesgo-treat-her2-positive-breast-cancer/) - On 29 June 2020, a novel fixed-dose combination of trastuzumab, pertuzumab, and hyaluronidase–zzxf (PHESGO, Genentech, Inc.) for subcutaneous injection to treat HERS-2 (human epidermal growth factor receptor 2) positive breast cancer was approved by US FDA (United States Food and Drug Administration). It can be used in combination with chemotherapy as neoadjuvant treatment of patients
- [Pembrolizumab receives FDA-approval to treat cSCC](https://admaconcology.com/pembrolizumab-receives-fda-approval-to-treat-cscc/) - On 24 June 2020, the US FDA (United States Food and Drug Administration) granted its approval to pembrolizumab (KEYTRUDA) for patients having recurrent or metastatic cSCC (cutaneous squamous cell carcinoma) that is not curable by surgery or radiation. A multicentre, multi-cohort, non-randomized, open-label trial (KEYNOTE-629) was conducted to explore the efficacy of pembrolizumab. Notably, those
- [Combination of chemo-immunotherapy is beneficial for mesothelioma treatment](https://admaconcology.com/chemo-immunotherapy-for-mesothelioma-treatment/) - At the annual meeting (held virtually from 29 May to 31 May 2020) of the ASCO (American Society of Clinical Oncology), a researcher from the Johns Hopkins Kimmel Cancer Center revealed that a combination of chemotherapy/immunotherapy can be utilized for first-line treatment of malignant pleural mesothelioma. Inoperable malignant pleural mesothelioma, a rare and aggressive cancer,
- [Study evaluates Infigratinib for Cholangiocarcinoma and FGFR2 fusions](https://admaconcology.com/infigratinib-for-cholangiocarcinoma-and-fgfr2-fusions/) - At ESMO (European Society for Medical Oncology) World Congress on Gastrointestinal Cancer 2020 Virtual, it was reported that in patients with CCA (cholangiocarcinoma) and FGFR2 (fibroblast growth factor receptor 2) fusions, outcomes from second-line chemotherapy are comparable to those reported in the literature for all CCA patients regardless of genomic status. In patients with CCA
- [Olaparib has similar safety in germline mutated pancreatic cancer across all age groups](https://admaconcology.com/olaparib-has-similar-safety-in-germline-mutated-pancreatic-cancer-across-all-age-groups/) - At ESMO World Congress on Gastrointestinal Cancer 2020 Virtual (1-4 July), the findings of additional analysis of the POLO trial in Chicago depicted that in patients with a germline BRCA1 and/or BRCA2 mutation and metastatic pancreatic cancer, the efficacy and safety of maintenance olaparib is consistent irrespective of age. Furthermore, from the maintenance treatment, a
- [Lurbinectedin receives FDA-approval to treat metastatic SCLC](https://admaconcology.com/fda-approves-lurbinectedin-to-treat-metastatic-sclc/) - For adult patients with metastatic SCLC (small cell lung cancer) with disease progression on or after platinum-based chemotherapy, lurbinectedin (ZEPZELCA, Pharma Mar S.A.) received FDA (Food and Drug Administration) accelerated approval on 15 June 2020. A multicentre open-label, multi-cohort (PM1183-B-005-14) trial aimed to explore the efficacy of lurbinectedin in105 adult patients with metastatic SCLC. Participants
- [Gemtuzumab ozogamicin receives FDA-approval for CD33-positive acute myeloid leukemia in pediatrics](https://admaconcology.com/fda-approves-gemtuzumab-ozogamicin/) - For newly diagnosed CD33-positive AML (acute myeloid leukemia), the FDA (Food and Drug Administration) extended the indication of gemtuzumab ozogamicin (MYLOTARG, Wyeth Pharmaceuticals LLC) on 16 June 2020 to include pediatric patients one month and older. A multicentre randomized (AAML0531) study was conducted to explore the safety and efficacy of gemtuzumab ozogamicin in 1,063 patients
- [Nivolumab receives FDA approval for esophageal squamous cell carcinoma](https://admaconcology.com/nivolumab-for-esophageal-squamous-cell-carcinoma/) - Nivolumab received Food and Drug Administration (FDA) approval on 10 June 2020 for managing patients with unresectable advanced, recurrent, or metastatic esophageal squamous cell carcinoma (ESCC) after prior use of fluoropyrimidine and platinum-based chemotherapy. A randomized (1:1), multicenter, active-controlled, open-label trial (ATTRACTION-3) was conducted to determine the efficacy of nivolumab in 419 patients with unresectable
- [Avapritinib's conditional marketing authorization granted by EMA](https://admaconcology.com/avapritinibs-conditional-marketing-authorization-granted-by-ema/) - The EMA's (European Medicines Agency) Committee for Medicinal Products for Human Use adopted a positive view, advocating the granting of a conditional marketing authorization for avapritinib on 23 July 2020 and this medicinal product will be available as film-coated 100 mg, 200 mg, and 300 mg tablets. It is intended for managing adult patients having
- [FDA granted approval to Pembrolizumab for Colorectal Cancer Treatment](https://admaconcology.com/fda-approves-pembrolizumab-for-colorectal-cancer-treatment/) - For the first-line treatment of patients with unresectable or metastatic MSI-H (microsatellite instability-high) or dMMR (mismatch repair deficient) colorectal cancer, the United States Food and Drug Administration (US FDA) granted its approval to pembrolizumab on 29 June 2020. A multicentre, open-label, active-controlled, randomized study recruiting 307 patients having MSI-H/dMMR colorectal cancer was conducted. Using polymerase
- [Pyrotinib could be the choice of drug in chemotherapy treated HER2-mutant NSCLC patients](https://admaconcology.com/pyrotinib-could-be-the-choice-of-drug-in-chemotherapy-treated-her2-mutant-nsclc-patients/) - In China, a study depicted that in patients with HER2 (human epidermal growth factor receptor-2)-mutated advanced NSCLC (non-small cell lung cancer), pyrotinib 400 mg daily may be given to patients who had received at least one prior platinum-based chemotherapy. Prophylactic loperamide may be given to avoid diarrhea, the most frequent noxious event occurring due to
- [Study to evaluate the efficacy of sintilimab in combination with bevacizumab biosimilar in advanced HCC patients](https://admaconcology.com/study-to-evaluate-the-efficacy-of-sintilimab-in-combination-with-bevacizumab-biosimilar/) - Sintilimab combined with a bevacizumab biosimilar has improved survival when used as first-line treatment of advanced hepatocellular carcinoma (HCC) patients in comparison to sorafenib. From a recent study, it was concluded that the combination of sintilimab and bevacizumab biosimilar has considerably enhanced survival. In this study patients suffering from metastatic HCC were included. Three hundred-eighty
- [Selpercatinib receives FDA approval for treating thyroid and lung cancers](https://admaconcology.com/selpercatinib-receives-fda-approval-for-treating-thyroid-and-lung-cancers/) - The U.S. Food and Drug Administration approved selpercatinib capsules for the treatment of explicitly following cancers: • Non-small cell lung cancer (NSCLC) in adults • Advanced RET fusion-positive thyroid cancer patients (twelve years or older), which needs systemic therapy that stopped giving response to radioactive iodine treatment or is not suitable for radioactive iodine therapy.
- [Capmatinib receives FDA approval to treat Lung Cancer](https://admaconcology.com/capmatinib-receives-fda-approval-to-treat-lung-cancer/) - The U.S. Food and Drug Administration approved Capmatinib to treat the non-small cell lung cancer (NSCLC) in adult patients. Capmatinib is the first FDA-approved treatment for NSCLC with specific mutations that result in mesenchymal-epithelial transition (MET) exon 14 skipping. Nearly all patients were with tumour samples, which were tested for mutations leading to MET exon
- [Ripretinib receives FDA approval to treat the Advanced Gastrointestinal Stromal Tumours](https://admaconcology.com/ripretinib-receives-fda-approval/) - The U.S. Food and Drug Administration approves Ripretinib tablets as the first new drug as a fourth-line therapy for treating the advanced gastrointestinal stromal tumour (GIST). GIST is a type of tumour, which begins in the gastrointestinal tract. Ripretinib is indicated for the patients (adults) who were previously treated with three or more kinase inhibitor
- [Tazemetostat receives FDA approval for the treatment of epithelioid sarcoma](https://admaconcology.com/tazemetostat-receives-fda-approval-for-the-treatment-of-epithelioid-sarcoma/) - The U.S. Food and Drug Administration approved tazemetostat for treating adults and pediatric patients of age 16 and older suffering from metastatic or locally advanced epithelioid sarcoma not appropriate for complete resection. Tazemetostat inhibits the activity of the EZH2 methyltransferase that might assist the growth of cancer cells. The majority cases of epithelioid sarcoma start
- [Margetuximab receives FDA approval for treating Breast Cancer](https://admaconcology.com/margetuximab-receives-fda-approval-for-breast-cancer/) - The margetuximab-cmkb combined with chemotherapy got approval from the Food and Drug Administration to treat metastatic HER2-positive breast cancer in adult patients who have received two or more previous anti-HER2 treatments in which at least one was meant for the metastatic disorder. Efficiency was assessed in an open-label trial conducted in five hundred and thirty-six
- [Relugolix receives FDA Approval for treatment of Advanced Prostate Cancer](https://admaconcology.com/relugolix-receives-fda-approval-for-advanced-prostate-cancer/) - The Relugolix got approval from U.S. Food and Drug Administration for treating advanced prostate cancer in adult patients. Relugolix is administered through the oral route, which inhibits the pituitary gland from producing follicle-stimulating hormone and luteinizing hormone. Thus it decreases the testosterone amounts which are produced by the testicles. The safety and efficiency of Relugolix
- [Alpelisib receives FDA Approval to treat Breast Cancer](https://admaconcology.com/fda-approves-alpelisib-to-treat-breast-cancer/) - Alpelisib got approval from the FDA to treat breast cancer when the tumours in patients have some genetic mutation. It is a targeted therapy called a PI3K inhibitor, particularly for advanced breast cancer patients. Alpelisib is to be used with fulvestrant, which is hormone therapy. It is the first drug that received approval under the
- [Study to find the safety of Palbociclib plus Endocrine Therapy for Breast Cancer](https://admaconcology.com/study-of-palbociclib-plus-endocrine-therapy-for-breast-cancer/) - A five year, the long-term assessment revealed the safety and consistency of palbociclib plus endocrine therapy for HR+/HER2- advanced breast cancer patients. Data were collected from the three randomized studies performed on patients with HR+/HER2- advanced breast cancer that included the postmenopausal women who had not gone through any previous systemic therapy for advanced disorder
- [Oral Contraceptives Protect Against Endometrial and ovarian Cancer](https://admaconcology.com/oral-contraceptives-protect-against-endometrial-and-ovarian-cancer/) - A much longer follow up was carried out compared to the most previous studies to demonstrate that use of oral contraceptive provides a protective effect against the endometrial and ovarian cancers up to 30-35 years after the discontinuation. This study was performed to explain the time-dependent effects linking the use of long-term oral contraceptive and
- [Effects of olaparib on Metastatic Castration-Resistant Prostate Cancer](https://admaconcology.com/effects-of-olaparib-on-metastatic-castration-resistant-prostate-cancer/) - Olaparib provides considerably longer imaging-based progression-free survival than the enzalutamide or abiraterone when received by men who have metastatic castration-resistant prostate cancer who undergo BRCA1, BRCA2, or ATM mutations and who experienced disease progression while getting a new hormonal agent. In a randomized study, olaparib was evaluated in men suffering from metastatic castration-resistant prostate cancer
- [FDA Approves naxitamab-gqgk for treating Neuroblastoma](https://admaconcology.com/fda-approves-naxitamab-gqgk-for-treating-neuroblastoma/) - U.S. Food and Drug Administration has approved naxitamab-gqgk 40mg/10ml. It is indicated in combination with granulocyte-macrophage colony-stimulating factor (“GM-CSF”) for pediatric patients of one year or above that and adult patient’s treatment who were suffering from relapsed high-risk neuroblastoma in the bone marrow or bone that have shown a incomplete response or stable disorder to
- [Avelumab as maintenance therapy to treat bladder cancer](https://admaconcology.com/avelumab-therapy-for-bladder-cancer/) - The US FDA (United States Food and Drug Administration) granted its approval to a novel drug avelumab (Bavencio) as maintenance therapy for patients suffering from locally advanced or metastatic urothelial carcinoma that has not yet advanced with first-line platinum-containing chemotherapy on 30 June 2020. A randomized, multicenter, phase 3, open-label, parallel-arm (JAVELIN Bladder 100) study

## Pages

- [HOME](https://admaconcology.com/) - We have a dedicated Oncology facility that manufactures Anti-cancer drugs - Tablet, Capsule, Liquid & Lyophilised Injection. We are ISO 9001:2000 certified.
- [LIST OF COPP](https://admaconcology.com/list-of-copp/) - LYOPHILIZED INJECTIONS BORTEZOMIB 2 MG BORTEZOMIB 3.5 MG DOXORUBICIN HYDROCHLORIDE 10 MG DOXORUBICIN HYDROCHLORIDE 50 MG EPIRUBICIN HYDROCHLORIDE 10 MG EPIRUBICIN HYDROCHLORIDE 50 MG EPIRUBICIN HYDROCHLORIDE 100 MG FLUDARABINE PHOSPHATE 50 MG GEMCITABINE 200 MG GEMCITABINE 1000 MG GEMCITABINE 1.4 GM OXALIPLATIN 50 MG OXALIPLATIN 100 MG PEMETREXED 100 MG PEMETREXED 500 MG ZOLEDRONIC ACID
- [About Us](https://admaconcology.com/about-us/) - Admac Lifesciences - a cancer drug manufacturing company in India, fully committed towards WHO GMP standards; quality & growth, latest technology & R & D.
- [CAREER](https://admaconcology.com/career/) - Looking to embark upon a successful career? Your search ends here! ADMAC - an Oncology Company has a lot to offer. Explore careers with a dedicated facility.
- [LIST OF PRODUCTS](https://admaconcology.com/list-of-products/) - Find information about individual cancer drug or list of anti cancer drugs at admac life sciences, committed towards WHO-GMP standards. ISO 9001:2000 certified.
- [CONTACT US](https://admaconcology.com/contact-us/) - We are leading Oncology company, & aim to facilitate hospitals & other healthcare organizations to max their potential with innovative quality healthcare products
- [PRODUCTS](https://admaconcology.com/products/)
- [Cart](https://admaconcology.com/cart/)
- [Home](https://admaconcology.com/home/)

## Products

- [Benzigem 200/100 Lyophilized Injection](https://admaconcology.com/product/benzigem-200-100-lyophilized-injection/) - Generic Name- Gemcitabine hydrochloride Drug Class – Antineoplastic agent Gemcitabine is a pyrimidine nucleoside antimetabolite which exhibits anti-tumor activity against a variety of solid tumors including non-small cell lung cancer, pancreatic, bladder, ovarian and breast cancer. It acts by inhibiting ribonucleotide reductase and also competes with deoxycytidine triphosphate for incorporation into DNA. Both these processes results in inhibition of DNA synthesis, leading to apoptosis and cell death. Dosage and Administration Recommended dose in NSCLC: 1000 mg/m2 over 30 minutes on Days 1, 8, and 15 of each 28-day cycle or 1250 mg/m2 over 30 minutes on Days 1 and 8 of each 21-day cycle Recommended dose in breast cancer: 1250 mg/m2 over 30 minutes on Days 1 and 8 of each 21­ day cycle Recommended dose in ovarian cancer: 1000 mg/m2 over 30 minutes on Days 1 and 8 of each 21-day cycle Recommended dose in pancreatic cancer: 1000 mg/m2 over 30 minutes once weekly for the first 7 weeks, then one week rest, then once weekly for 3 weeks of each 28-day cycle2 Dosage Form and Strength Supplied as a single-use vial containing lyophilized powder for intravenous use only Available as 100mg and 200mg for injection
- [Epribenz 50/10 Lyophilized Injection](https://admaconcology.com/product/epribenz-10-50-lyophilized-injection/) - Generic Name – Epirubicin hydrochloride Drug Class – Antineoplastic agent Epirubicin is an anthracycline topoisomerase II inhibitor, which is derived from doxorubicin. It is the most active single agent used in the management of patients with breast cancer. It produces its antitumor and cytotoxic effects by inhibiting nucleic acid and protein synthesis. Dosage and Administration Recommended dose of Epirubicin is 100 to 120 mg/m2, administered intravenously in repeated 3- to 4-week cycles, either total dose on Day 1 of each cycle or divided equally and given on Days 1 and 8 of each cycle. Dose may be reduced when given in certain combinations Dosage Form and Strength Supplied as a single use vial containing sterile lyophilized powder for intravenous use Available as 10mg and 50mg for injection
- [N-Zal 40 Capsule](https://admaconcology.com/product/n-zal-40-80-capsule/) - Generic Name- Enzalutamide Drug Class – Antineoplastic Agent / Androgen Receptor Inhibitor Enzalutamide is an oral chemotherapy drug used to treat metastatic castration-resistant prostate cancer (mCRPC). It works by inhibiting androgen receptors, which prevents testosterone from stimulating prostate cancer cell growth. Enzalutamide is administered orally in capsule form under medical supervision and is usually used in combination with androgen deprivation therapy. Common side effects include fatigue, hot flashes, headache, dizziness, diarrhea, muscle weakness, and increased risk of seizures in rare cases. Dosage: Available in 40 mg and 80 mg capsules Category: Oral Capsule
- [Admatrex 15/50 Liquid Injection](https://admaconcology.com/product/admatrex-50-500-liquid-injection/) - Generic Name- Methotrexate Drug Class – Antineoplastic Agent / Antimetabolite / Immunosuppressant Methotrexate is a chemotherapy drug used to treat various cancers, including leukemia, lymphoma, breast cancer, and osteosarcoma. It works as an antimetabolite by inhibiting dihydrofolate reductase, an enzyme needed for DNA synthesis, thereby slowing or stopping the growth of cancer cells. Methotrexate is administered by intravenous (IV) infusion, intramuscular (IM), or intrathecal injection in hospital settings. It is also used in lower doses for autoimmune diseases such as rheumatoid arthritis and psoriasis. Common side effects include nausea, vomiting, mouth sores, low blood counts, and liver toxicity. Dosage: Available in 50 mg/2 mL and 500 mg/20 mL strengths Category: Liquid Injection
- [Afamac 20/30/40/50 Tablets](https://admaconcology.com/product/afamac-20-30-40-50-tablets/) - Generic Name- Afatinib Drug Class – Antineoplastic Agent / Tyrosine Kinase Inhibitor (TKI) Afatinib is an oral chemotherapy drug used for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations, and for certain cases of squamous cell carcinoma of the lung progressing after platinum-based chemotherapy. It works by irreversibly inhibiting the ErbB family of receptor tyrosine kinases (including EGFR, HER2, and HER4), thereby blocking signal transduction pathways responsible for cancer cell growth and proliferation. Afatinib is administered orally in tablet form, typically once daily, under the supervision of an oncologist. It may be used as first-line therapy in EGFR mutation–positive NSCLC patients. Common side effects include diarrhea, rash, stomatitis, decreased appetite, paronychia, and dry skin. Dose adjustments may be required based on tolerance and adverse reactions. Dosage: Available in 20 mg, 30 mg, 40 mg, and 50 mg tablets Category: Oral Tablet
- [Admabucil Tablets](https://admaconcology.com/product/admabucil-tablets/) - Generic Name- Chlorambucil Drug Class – Antineoplastic Agent / Alkylating Agent Chlorambucil is an oral chemotherapy drug primarily used in the treatment of chronic lymphocytic leukemia (CLL), Hodgkin’s lymphoma, and certain types of non-Hodgkin’s lymphomas. It works by interfering with the DNA replication process in cancer cells, leading to inhibition of cell division and tumor growth. Chlorambucil is administered orally in tablet form, typically under the supervision of an oncologist. The dosage and duration depend on the patient’s condition and response to treatment. Common side effects include bone marrow suppression, nausea, vomiting, diarrhea, mouth sores, and rash. Long-term use may increase the risk of secondary malignancies. Dosage: Available in 2 mg tablets
- [Admapag 25/50 Tablets](https://admaconcology.com/product/admapag-25-50-tablets/) - Generic Name- Eltrombopag Olamine Drug Class – Thrombopoietin Receptor Agonist Eltrombopag Olamine is an oral medication used to treat thrombocytopenia (low platelet count) in patients with chronic immune thrombocytopenia (ITP), severe aplastic anemia, and chronic hepatitis C–associated thrombocytopenia. It works by stimulating the thrombopoietin receptor (TPO-R) on bone marrow cells, thereby promoting platelet production. Eltrombopag is administered orally in tablet form and should be taken on an empty stomach, either 1 hour before or 2 hours after meals, as directed by a healthcare professional. Common side effects include headache, nausea, fatigue, liver function abnormalities, and upper respiratory tract infections. Periodic monitoring of liver enzymes and platelet counts is recommended during treatment. Dosage:Available in 25 mg and 50 mg tablets
- [Admarib-100/150](https://admaconcology.com/product/admarib-100-150/) - Generic Name- Olaparib Drug Class – Antineoplastic Agent / PARP (Poly ADP-Ribose Polymerase) Inhibitor Olaparib is an oral chemotherapy drug used to treat certain types of cancers associated with BRCA1/2 mutations, including ovarian, breast, pancreatic, and prostate cancers. It works by inhibiting the PARP enzyme, which is involved in DNA repair. By blocking this enzyme, Olaparib causes cancer cells with defective DNA repair mechanisms to accumulate damage and undergo cell death. Olaparib is administered orally in tablet form, usually under the supervision of an oncologist, and may be used as monotherapy or in combination with other treatments. Common side effects include nausea, fatigue, anemia, vomiting, diarrhea, decreased appetite, and respiratory infections. Blood counts should be monitored regularly during therapy. Dosage: Available in 100 mg and 150 mg tablets Category: Oral Tablet
- [Admatrone 250/500 Tablets](https://admaconcology.com/product/admatrone-250-500-tablets/) - Generic Name- Abiraterone Acetate Drug Class – Antineoplastic Agent / Androgen Biosynthesis Inhibitor Abiraterone Acetate is an oral medication used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC). It works by selectively inhibiting the enzyme CYP17A1, which is essential for androgen biosynthesis in the testes, adrenal glands, and prostate tumor tissue. This inhibition reduces androgen production, slowing the growth of androgen-dependent prostate cancer cells. Abiraterone is administered orally in tablet form, typically in combination with prednisone and under the supervision of an oncologist. It should be taken on an empty stomach, at least one hour before or two hours after meals. Common side effects include hypertension, hypokalemia, fluid retention, fatigue, joint pain, and elevated liver enzymes. Regular monitoring of liver function and electrolytes is recommended during therapy. Dosage: Available in 250 mg and 500 mg tablets Category: Oral Tablet
- [Admazole 2.5 Tablets](https://admaconcology.com/product/admazole-2-5-tablets/) - Generic Name- Letrozole Drug Class – Antineoplastic Agent / Aromatase Inhibitor Letrozole is an oral hormonal therapy used primarily in the treatment of hormone receptor–positive breast cancer in postmenopausal women. It works by inhibiting the aromatase enzyme, which is responsible for the conversion of androgens to estrogens. By reducing estrogen levels in the body, Letrozole helps slow or stop the growth of estrogen-dependent cancer cells. Letrozole is administered orally in tablet form, usually once daily, with or without food, under the supervision of an oncologist. It may also be used as adjuvant therapy, extended adjuvant therapy, or in cases of advanced or metastatic breast cancer. Common side effects include hot flashes, fatigue, joint pain, nausea, dizziness, and increased cholesterol levels. Bone density monitoring is recommended during long-term treatment. Dosage:Available in 2.5 mg tablets Category: Oral Tablet
- [Aximac 1/5 Tablets](https://admaconcology.com/product/aximac-1-5-tablets/) - Generic Name- Axitinib Drug Class – Antineoplastic Agent / Tyrosine Kinase Inhibitor (TKI) Axitinib is an oral targeted therapy used in the treatment of advanced renal cell carcinoma (RCC) and other cancers as indicated by an oncologist. It works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, and VEGFR-3), which play a key role in tumor angiogenesis and cancer cell proliferation. By blocking these pathways, Axitinib helps reduce blood supply to the tumor, thereby slowing its growth. Axitinib is administered orally in tablet form, usually twice daily, with or without food, under medical supervision. The dose may be adjusted based on the patient’s tolerance and clinical response. Common side effects include hypertension, fatigue, diarrhea, decreased appetite, nausea, and hand-foot syndrome. Blood pressure and liver function should be monitored regularly during treatment. Dosage: Available in 1 mg and 5 mg tablets Category: Oral Tablet
- [Captomac Tablets](https://admaconcology.com/product/captomac-tablets/) - Generic Name- Mercaptopurine Drug Class – Antineoplastic Agent / Antimetabolite (Purine Analog) Mercaptopurine is an oral chemotherapy drug used in the treatment of acute lymphoblastic leukemia (ALL) and other hematologic malignancies. It works by interfering with DNA and RNA synthesis in rapidly dividing cells, thereby inhibiting cancer cell growth and proliferation. Mercaptopurine is administered orally in tablet form, usually once daily, under the supervision of an oncologist. The dosage is individualized based on patient response, disease type, and tolerance. Common side effects include bone marrow suppression, nausea, vomiting, diarrhea, liver toxicity, and loss of appetite. Regular monitoring of complete blood counts and liver function tests is essential during therapy. Dosage: Available in 10 mg tablets Category: Oral Tablet
- [Dasamac 50/70 Tablets](https://admaconcology.com/product/dasamac-50-70-tablets/) - Generic Name- Dasatinib Drug Class – Antineoplastic Agent / Tyrosine Kinase Inhibitor (BCR-ABL Inhibitor) Dasatinib is an oral targeted therapy used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL). It works by inhibiting multiple tyrosine kinases, including BCR-ABL and SRC family kinases, which are involved in cancer cell growth and survival. By blocking these enzymes, Dasatinib helps prevent the proliferation of leukemia cells. Dasatinib is administered orally in tablet form, usually once daily, with or without food, under the supervision of a hematologist or oncologist. Common side effects include myelosuppression, fluid retention, pleural effusion, diarrhea, fatigue, and rash. Regular monitoring of blood counts and fluid status is recommended during treatment. Dosage: Available in 50 mg and 70 mg tablets Category: Oral Tablet
- [Pazolee 200/400 Tablets](https://admaconcology.com/product/pazolee-200-400-tablets/) - Generic Name- Pazopanib Drug Class – Antineoplastic Agent / Tyrosine Kinase Inhibitor (VEGFR, PDGFR, KIT Inhibitor) Pazopanib is an oral targeted therapy used in the treatment of advanced renal cell carcinoma (RCC) and soft tissue sarcoma. It works by inhibiting multiple receptor tyrosine kinases, including VEGFR, PDGFR, and KIT, which are involved in tumor angiogenesis and cancer cell proliferation. By blocking these pathways, Pazopanib helps slow tumor growth and reduce blood supply to the cancer. Pazopanib is administered orally in tablet form, usually once daily on an empty stomach, under the supervision of an oncologist. Dose adjustments may be required based on tolerance and clinical response. Common side effects include hypertension, diarrhea, hair color changes, nausea, fatigue, liver toxicity, and hand-foot syndrome. Liver function tests and blood pressure should be monitored regularly during therapy. Dosage: Available in 200 mg and 400 mg tablets Category: Oral Tablet
- [Sorabenz Tablets](https://admaconcology.com/product/sorabenz-tablets/) - Generic Name- Sorafenib Drug Class – Antineoplastic Agent / Tyrosine Kinase Inhibitor (Multi-Targeted TKI) Sorafenib is an oral targeted therapy used in the treatment of advanced hepatocellular carcinoma (HCC), advanced renal cell carcinoma (RCC), and certain types of thyroid cancer. It works by inhibiting multiple receptor tyrosine kinases, including VEGFR, PDGFR, and RAF kinases, which play key roles in tumor cell proliferation and angiogenesis. By blocking these pathways, Sorafenib helps slow tumor growth and reduce blood supply to the cancer. Sorafenib is administered orally in tablet form, usually twice daily, under the supervision of an oncologist. Dose adjustments may be needed based on tolerance and side effects. Common side effects include diarrhea, hand-foot syndrome, hypertension, fatigue, rash, nausea, and liver function abnormalities. Regular monitoring of liver function, blood pressure, and overall clinical status is recommended during therapy. Dosage: Available in 200 mg tablets Category: Oral Tablet
- [Palbenz 75/100/125 Capsule](https://admaconcology.com/product/palbenz-75-100-125-capsule/) - Generic Name- Palbociclib Drug Class – Antineoplastic Agent / Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor Palbociclib is an oral chemotherapy drug used to treat hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK4/6), which slows cancer cell division and tumor growth. Palbociclib is administered orally in capsule form under medical supervision and is usually used in combination with endocrine therapy, such as letrozole or fulvestrant. Common side effects include neutropenia (low white blood cell counts), fatigue, nausea, diarrhea, infections, and hair thinning. Dosage: Available in 75 mg, 100 mg, and 125 mg capsules Category: Oral Capsule
- [Admaone capsules](https://admaconcology.com/product/admaone-capsules/) - Generic Name- Acalabrutinib Drug Class – Antineoplastic Agent / Bruton's Tyrosine Kinase (BTK) Inhibitor Acalabrutinib is an oral chemotherapy drug used to treat chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It works by inhibiting Bruton's tyrosine kinase (BTK), a key enzyme in B-cell signaling, which slows the growth and survival of cancerous B-cells. Acalabrutinib is administered orally in capsule form under medical supervision and may be used alone or in combination with other targeted therapies. Common side effects include headache, diarrhea, fatigue, bruising, low blood counts, and infections. Dosage: Available in 100 mg capsules Category: Oral Capsule
- [Crizano 250 Capsule](https://admaconcology.com/product/crizano-250-capsule/) - Generic Name- Crizotinib Drug Class – Antineoplastic Agent / ALK and ROS1 Tyrosine Kinase Inhibitor Crizotinib is an oral chemotherapy drug used to treat non-small cell lung cancer (NSCLC) that is ALK-positive or ROS1-positive. It works by inhibiting anaplastic lymphoma kinase (ALK) and ROS1, proteins involved in cancer cell growth, which slows the proliferation of cancerous cells. Crizotinib is administered orally in capsule form under medical supervision and may be used alone or in combination with other targeted therapies. Common side effects include vision changes, nausea, vomiting, diarrhea, constipation, swelling of hands or feet, and fatigue. Dosage: Available in 200 mg and 250 mg capsules Category: Oral Capsule
- [Lenabenz 5/10/25 Capsule](https://admaconcology.com/product/lenabenz-5-10-25-capsule/) - Generic Name- Lenalidomide Drug Class – Antineoplastic Agent / Immunomodulatory Drug (IMiD) Lenalidomide is an oral chemotherapy drug used to treat multiple myeloma, mantle cell lymphoma (MCL), and certain types of myelodysplastic syndromes (MDS). It works by modulating the immune system and inhibiting the growth of cancerous cells, which slows disease progression. Lenalidomide is administered orally in capsule form under medical supervision and may be used alone or in combination with other therapies, such as dexamethasone. Common side effects include fatigue, diarrhea, constipation, low blood counts (anemia, neutropenia, thrombocytopenia), rash, and increased risk of infections. Dosage: Available in 5 mg, 10 mg, and 25 mg capsules Category: Oral Capsule
- [Pomamac 1/2/4 Capsule](https://admaconcology.com/product/pomamac-1-2-4-capsule/) - Generic Name- Pomalidomide Drug Class – Antineoplastic Agent / Immunomodulatory Drug (IMiD) Pomalidomide is an oral chemotherapy drug used to treat multiple myeloma in patients who have received prior therapies, including lenalidomide and a proteasome inhibitor. It works by modulating the immune system and inhibiting the growth of cancerous plasma cells, which helps control disease progression. Pomalidomide is administered orally in capsule form under medical supervision and is usually used in combination with dexamethasone. Common side effects include fatigue, constipation, diarrhea, low blood counts (anemia, neutropenia, thrombocytopenia), rash, and increased risk of infections. Dosage: Available in 1 mg, 2 mg, and 4 mg capsules Category: Oral Capsule
- [Sunitibenz 25/50/12.5 Capsule](https://admaconcology.com/product/sunitibenz-25-50-12-5-capsule/) - Generic Name- Sunitinib Drug Class – Antineoplastic Agent / Tyrosine Kinase Inhibitor (TKI) Sunitinib is an oral chemotherapy drug used to treat renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNETs). It works by inhibiting multiple tyrosine kinases, including VEGFR and PDGFR, which slows tumor growth and blocks the formation of new blood vessels that supply cancer cells. Sunitinib is administered orally in capsule form under medical supervision and may be used alone or in combination with other therapies. Common side effects include fatigue, diarrhea, nausea, vomiting, high blood pressure, hand-foot syndrome, and mouth sores. Serious side effects can include heart problems, liver toxicity, bleeding, and severe infections. Dosage: Available in 12.5 mg, 25 mg, and 50 mg capsules Category: Oral Capsule
- [Tasibenz 150 Capsule](https://admaconcology.com/product/tasibenz-150-capsule/) - Generic Name- Nilotinib Drug Class – Antineoplastic Agent / Tyrosine Kinase Inhibitor (TKI) Nilotinib is an oral chemotherapy drug used to treat chronic myeloid leukemia (CML), particularly in patients who are newly diagnosed or resistant/intolerant to prior therapies such as imatinib. It works by selectively inhibiting the BCR-ABL tyrosine kinase, which slows the growth and survival of leukemia cells. Nilotinib is administered orally in capsule form under medical supervision and may be used alone or in combination with other treatments. Common side effects include headache, fatigue, nausea, constipation, rash, and elevated blood sugar or liver enzymes. Serious side effects can include heart rhythm changes (QT prolongation), pancreatitis, and severe myelosuppression. Dosage: Available in 150 mg, 200 mg, and 300 mg capsules Category: Oral Capsule
- [Adlen 4/10 Capsules](https://admaconcology.com/product/adlen-4-10-capsules/) - Generic Name- Lenvatinib Drug Class – Antineoplastic Agent / Tyrosine Kinase Inhibitor Lenvatinib is an oral chemotherapy drug used to treat differentiated thyroid cancer, hepatocellular carcinoma, and renal cell carcinoma. It works by inhibiting multiple receptor tyrosine kinases (RTKs), which are involved in tumor angiogenesis and cancer cell proliferation. Lenvatinib is administered orally in capsule form, usually under the supervision of an oncologist, and may be used alone or in combination with other therapies. Common side effects include hypertension, fatigue, diarrhea, decreased appetite, weight loss, and nausea. Dosage: Available in 4 mg and 10 mg capsules Category: Oral Capsule
- [Carbenz 150/450 Liquid Injection](https://admaconcology.com/product/carbenz-150-450-liquid-injection-2/) - Generic Name- Carboplatin Drug Class – Antineoplastic Agent (Platinum Compound) Carboplatin is a chemotherapy drug used to treat various cancers, including ovarian cancer, lung cancer, head and neck cancers, and testicular cancer. It works by binding to DNA in cancer cells, causing cross-links that prevent DNA replication and cell division, leading to cancer cell death. Carboplatin is administered by intravenous (IV) infusion in hospital settings and may be used alone or in combination with other chemotherapy drugs. Common side effects include nausea, vomiting, low blood counts, kidney toxicity, and fatigue. Dosage: Available in 150 mg and 450 mg strengths Category: Liquid Injection
- [Adcarfil 60 Liquid Injection](https://admaconcology.com/product/adcarfil-60-liquid-injection/) - Generic Name- Carfilzomib Drug Class – Antineoplastic agent Carfilzomib is a chemotherapy drug used to treat multiple myeloma, a type of blood cancer. It works as a proteasome inhibitor, blocking the breakdown of proteins in cancer cells, which leads to their death. Carfilzomib is administered by intravenous (IV) infusion in hospital settings. It is often used in combination with other medications such as lenalidomide and dexamethasone. Common side effects include fatigue, nausea, anemia, shortness of breath, and low platelet counts. Dosage: Available in 60mg strength Category: Liquid Injection
- [Admagin-P Liquid Injection](https://admaconcology.com/product/admagin-p-liquid-injection/) - Generic Name- Pegaspargase (Peg L-Asparaginase) Drug Class – Antineoplastic agent Peg L-Asparaginase is a chemotherapy drug used to treat acute lymphoblastic leukemia (ALL), a cancer of the white blood cells. It works by breaking down asparagine, an amino acid that leukemia cells need to survive, thereby inhibiting their growth. Peg L-Asparaginase is administered by intravenous (IV) infusion or intramuscular (IM) injection in hospital settings. It is often used in combination with other chemotherapy agents as part of multi-drug treatment regimens. Common side effects include allergic reactions, nausea, vomiting, fatigue, liver enzyme elevation, and pancreatitis. Dosage: Available in 3750 IU/5 mL strength Category: Liquid Injection
- [Admastem 24 Liquid Injection](https://admaconcology.com/product/admastem-24-liquid-injection/) - Generic Name- Plerixafor Drug Class – Hematopoietic Stem Cell Mobilizer / Antineoplastic Adjunct Plerixafor is used to mobilize hematopoietic stem cells from the bone marrow into the bloodstream for collection and transplantation in patients with lymphoma and multiple myeloma. It works as a CXCR4 chemokine receptor antagonist, helping release stem cells into peripheral blood for harvesting. Plerixafor is administered by subcutaneous injection in hospital or clinical settings. It is typically used in combination with granulocyte-colony stimulating factor (G-CSF). Common side effects include diarrhea, nausea, injection site reactions, dizziness, and fatigue. Dosage: Available in 24 mg/1.2 mL strength Category: Liquid Injection
- [Admatop 2.5 Liquid Injection](https://admaconcology.com/product/admatop-2-5-liquid-injection/) - Generic Name- Topotecan Drug Class – Antineoplastic Agent (Topoisomerase I Inhibitor) Topotecan is a chemotherapy drug used to treat ovarian cancer, small cell lung cancer, and cervical cancer. It works by inhibiting the enzyme topoisomerase I, which is essential for DNA replication, thereby preventing cancer cell growth and division. Topotecan is administered by intravenous (IV) infusion in hospital settings under medical supervision. It may be used alone or in combination with other chemotherapy drugs. Common side effects include nausea, vomiting, diarrhea, low blood counts (anemia, neutropenia, thrombocytopenia), and fatigue. Dosage: Available in 2.5 mg strength Category: Liquid Injection
- [Admoxel EZ 20/80/120 Liquid Injection](https://admaconcology.com/product/admoxel-ez-20-80-120-liquid-injection/) - Generic Name- Docetaxel (RTU – Ready to Use) Drug Class – Antineoplastic Agent (Taxane Derivative) Docetaxel is a chemotherapy drug used to treat various cancers, including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head & neck cancers. It works by inhibiting microtubule disassembly, disrupting cell division and leading to cancer cell death. RTU (Ready-to-Use) Docetaxel formulation simplifies preparation and minimizes handling risks in hospital settings. It is administered by intravenous (IV) infusion under medical supervision. Common side effects include fatigue, nausea, hair loss, low blood counts, fluid retention, and peripheral neuropathy. Dosage: Available in 20 mg/1 mL, 80 mg/4 mL, and 120 mg/6 mL strengths Category: Liquid Injection
- [Benzigem EZ 200/1000 Liquid Injection](https://admaconcology.com/product/benzigem-ez-200-1000-liquid-injection/) - Generic Name- Gemcitabine (RTU – Ready to Use) Drug Class – Antineoplastic Agent (Nucleoside Analog) Gemcitabine is a chemotherapy drug used to treat various cancers, including pancreatic cancer, non-small cell lung cancer, breast cancer, and bladder cancer. It works by interfering with DNA synthesis, preventing cancer cells from multiplying and leading to their death. The RTU (Ready-to-Use) formulation simplifies preparation and reduces handling risks in hospital settings. Gemcitabine is administered by intravenous (IV) infusion under medical supervision and may be used alone or in combination with other chemotherapy drugs. Common side effects include nausea, vomiting, fatigue, low blood counts, liver enzyme elevation, and flu-like symptoms. Dosage: Available in 200 mg/4 mL and 1000 mg/20 mL strengths Category: Liquid Injection
- [Cislee 10/50 Liquid Injection Cisplatin 10/50mg](https://admaconcology.com/product/cislee-10-50-liquid-injection-cisplatin-10-50mg/) - Generic Name- Cisplatin Drug Class – Antineoplastic Agent (Platinum Compound) Cisplatin is a chemotherapy drug used to treat various cancers, including ovarian, testicular, bladder, lung, and head & neck cancers. It works by forming cross-links in DNA, preventing cancer cells from replicating and leading to their death. Cisplatin is administered by intravenous (IV) infusion in hospital settings and is often used in combination with other chemotherapy agents. Common side effects include nausea, vomiting, kidney toxicity, low blood counts, and hearing changes. Dosage: Available in 10 mg and 50 mg strengths Category: Liquid Injection
- [Fulvimac 250 Liquid Injection](https://admaconcology.com/product/fulvimac-250-liquid-injection/) - Generic Name- Fulvestrant Drug Class – Antineoplastic Agent / Selective Estrogen Receptor Downregulator (SERD) Fulvestrant is a hormone therapy drug used to treat hormone receptor-positive (HR+) advanced or metastatic breast cancer in postmenopausal women. It works by binding to estrogen receptors, blocking and degrading them, which slows or stops the growth of estrogen-dependent cancer cells. Fulvestrant is administered by intramuscular (IM) injection in hospital or clinical settings. It may be used alone or in combination with other targeted therapies, depending on the patient’s treatment plan. Common side effects include injection site reactions, nausea, fatigue, hot flashes, and headache. Dosage: Available in 250 mg/5 mL strength Category: Liquid Injection
- [Itocad 100 Liquid Injection](https://admaconcology.com/product/itocad-100-liquid-injection/) - Generic Name- Etoposide Drug Class – Antineoplastic Agent (Topoisomerase II Inhibitor) Etoposide is a chemotherapy drug used to treat various cancers, including small cell lung cancer, testicular cancer, and lymphomas. It works by inhibiting the enzyme topoisomerase II, preventing DNA replication and leading to cancer cell death. Etoposide is administered by intravenous (IV) infusion or oral capsule in hospital settings and may be used alone or in combination with other chemotherapy drugs. Common side effects include nausea, vomiting, low blood counts, hair loss, and fatigue. Dosage: Available in 100 mg strength Category: Liquid Injection
- [Leevarin 50 Liquid Injection](https://admaconcology.com/product/leevarin-50-liquid-injection/) - Generic Name- Leucovorin Calcium Drug Class – Antineoplastic Adjunct / Folate Analog Leucovorin Calcium is used in cancer therapy to reduce the toxic effects of methotrexate and enhance the efficacy of fluorouracil (5-FU) in certain chemotherapy regimens. It works by providing a source of folinic acid, which helps normal cells recover from the effects of folate antagonists while allowing chemotherapy to target cancer cells. Leucovorin Calcium is administered by intravenous (IV) or intramuscular (IM) injection in hospital settings. Common side effects include allergic reactions, rash, fever, nausea, and flushing. Dosage: Available in 50 mg strength Category: Liquid Injection
- [Vinolee 10/50 Liquid Injection](https://admaconcology.com/product/vinolee-10-50-liquid-injection/) - Generic Name- Vinorelbine Drug Class – Antineoplastic Agent (Vinca Alkaloid) Vinorelbine is a chemotherapy drug used to treat non-small cell lung cancer and breast cancer. It works by inhibiting microtubule formation, which prevents cancer cells from dividing and leads to cell death. Vinorelbine is administered by intravenous (IV) infusion in hospital settings and may be used alone or in combination with other chemotherapy drugs. Common side effects include nausea, vomiting, low blood counts, constipation, fatigue, and peripheral neuropathy. Dosage: Available in 10 mg and 50 mg strengths Category: Liquid Injection
- [ADMAGIN 5000/10000 Lyophilized Injection](https://admaconcology.com/product/admagin-5000-10000-lyophilized-injection/) - Generic Name - L-Asparaginase Drug Class – Antineoplastic agent L-Asparaginase is an enzyme-based chemotherapy used mainly to treat acute lymphoblastic leukemia (ALL). It works by depleting L-asparagine, an amino acid essential for the survival of certain cancer cells. This leads to the inhibition of cancer cell growth and promotes cell death. It is administered via IV or IM injection and is part of combination chemotherapy protocols. Common side effects include allergic reactions, liver toxicity, and pancreatitis. Dosage Available in 5000 i.u and 10000 i.u strength
- [Nabtaxel](https://admaconcology.com/product/nabtaxel/) - Generic Name - Paclitaxel Protein bound 100 mg Drug Class – Antineoplastic agent Paclitaxel Protein-Bound is a nanoparticle albumin-bound formulation of paclitaxel used to treat breast cancer, non-small cell lung cancer, and pancreatic cancer. It works by stopping cancer cell division by stabilizing microtubules. This formulation allows for better tumor penetration and reduces the need for toxic solvents. Administered via intravenous (IV) infusion, often in combination with other agents. Common side effects include neuropathy, low blood counts, and fatigue. Dosage Available in 100 mg strength
- [Daunomac-20](https://admaconcology.com/product/daunomac-20/) - Generic Name - Daunorubicin Drug Class – Antineoplastic agent Daunorubicin is an anthracycline chemotherapy drug used to treat acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It works by interfering with DNA replication, leading to the death of rapidly dividing cancer cells. Daunorubicin is given by intravenous (IV) injection, usually in combination with other chemotherapies. It is a key component of induction therapy in leukemia treatment protocols. Common side effects include hair loss, low blood counts, and heart-related toxicity. Dosage Available in 20 mg strength
- [Azamac 100 Lyophilized Injection](https://admaconcology.com/product/azamac-100-lyophilized-injection/) - Generic Name - Azacitidine Drug Class – Antineoplastic agent Azacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS), acute myeloid leukemia (AML), and chronic myelomonocytic leukemia (CMML). It works as a hypomethylating agent, helping restore normal cell growth by reducing abnormal DNA methylation in cancer cells. Azacitidine is administered by subcutaneous injection or intravenous (IV) infusion in hospital settings. It may be used alone or in combination with other treatments depending on the cancer type. Common side effects include nausea, vomiting, fatigue, low blood counts, and injection site reactions. Dosage Available in 100 mg strength
- [ADZINE 200/500 Lyophilized Injection](https://admaconcology.com/product/adzine-200-500-lyophilized-injection/) - Generic Name - Dacarbazine Drug Class – Antineoplastic agent Dacarbazine is a chemotherapy drug used to treat Hodgkin’s lymphoma, melanoma, and other cancers. It works as an alkylating agent, damaging the DNA of cancer cells to stop their growth. Dacarbazine is administered by intravenous (IV) infusion in hospital settings. It is often used in combination with other chemotherapy drugs. Common side effects include nausea, vomiting, low blood counts, and fatigue. Dosage Available in 200 mg and 500 mg strength
- [Thailogem 50/100 Capsules](https://admaconcology.com/product/thailogem-50-100-capsules/) - Generic Name- Thalidomide Drug Class- Antineoplastic agent Thalidomide is an immunomodulatory agent, considered as a standard approach for the treatment of relapsed and refractory myeloma. It acts through several mechanisms such as antiangiogenic effects, induction of apoptosis or G1 arrest of the cell cycle, the inhibition of growth factor production, the regulation of interactions between tumor and stromal cells, and the modulation of tumor immunity.
- [Temobenz 20/100/250](https://admaconcology.com/product/temobenz-20-100-250/) - Generic Name: Temozolomide Drug Class: Antineoplastic; Alkylating agent Temozolomide is an oral alkylating agent which has shown promise in treating malignant gliomas and other difficult-to-treat tumors. It has been approved by FDA for the treatment of adult patients with refractory anaplastic astrocytoma and newly diagnosed glioblastoma. It acts by methylating guanine residues in DNA strand, which results in single and double strand breaks, thus causing cell cycle arrest and ultimately cell death. Dosage and Administration Recommended dose in newly diagnosed GBM: 75 mg/m2 for 42 days concomitant with focal radiotherapy followed by initial maintenance dose of 150 mg/m2 once daily for days 1-5 of a 28-day cycle of temozolomide for 6 cycles Recommended dose in refractory anaplastic astrocytoma: 150 mg/m2 once daily for 5 consecutive days per 28-day treatment cycle Dosage Form and Strength Supplied as capsules for oral use Available in 20mg, 100mg and 250 mg strength
- [Paclibenz 30/100/260 Liquid Injection](https://admaconcology.com/product/paclibenz-30-100-260-liquid-injection/) - Generic Name- Paclitaxel Drug Class- Antineoplastic agent Paclitaxel is an antimetabolite used for the therapy of different types of cancers including ovarian, breast, non small cell lung cancer and AIDS related Kaposi sarcoma. It acts by stabilizing microtubules and interfering with microtubule disassembly in cell division, resulting in cell cycle arrest and cell death.
- [Oxabenz 50/100 Liquid Injection](https://admaconcology.com/product/oxabenz-50-100-liquid-injection/) - Generic Name-> Oxaliplatin Drug Class- Antineoplastic agent Oxaliplatin is a platinum derived chemotherapeutic agent which is used for the treatment of advanced colorectal cancer. It exerts its cytotoxic effects by inhibiting DNA and RNA synthesis and formation of DNA lesions. These cytotoxic effects damages DNA, initiates apoptosis and ultimately cell death. Dosage and Administration The recommended dosing regimen of oxaliplatin is as follow: Oxaliplatin 85 mg/m2 IV and leucovorin 200 mg/m2 IV, both given over 120 minutes at the same time in separate bags using a Y-line, followed by 5-fluorouracil 400 mg/m2 intravenous bolus given over 2-4 minutes, followed by 5­ fluorouracil 600 mg/m2 IV, as a 22-hour continuous infusion on day 1 Leucovorin 200 mg/m2 intravenous infusion over 120 minutes, followed by 5-fluorouracil 400 mg/m2 IV bolus given over 2-4 minutes, followed by 5-fluorouracil 600 mg/m2 IV as a 22-hour continuous infusion on day 2 Administer oxaliplatin in combination with 5-fluorouracil/leucovorin every 2 weeks Dosage Form and Strengths Supplied as a single use vial containing aqueous solution for intravenous infusion Available as 50mg and 100mg for injection
- [Matibenz 400 Tablets](https://admaconcology.com/product/matibenz-400-tablets/) - Generic Name- Imatinib mesylate Drug Class- Antineoplastic agent Imatinib a tyrosine kinase inhibitor, which was initially approved for the treatment of chronic myeloid leukemia. Its use has now extended to various other cancers and has achieved first-line position in cancers like Ph+ ALL, advanced dermatofibrosarcoma protuberans (DFPS), hypereosinophilic syndrome (HS), and systemic mastocytosis (SM). It blocks constitutive action of protein tyrosine kinase by working as a competitive inhibitor of the ATP binding cleft of ABL inducing apoptosis of leukemic cells.
- [Leevarin 15 Tablets](https://admaconcology.com/product/leevarin-15-tablets/) - Generic Name- Leucovorin calcium Drug Class- Folate Analog Description- Leucovorin, also known as folinic acid, is a naturally occurring, reduced form of folic acid. It is usually indicated as an antidote to reduce toxic effects of methotrexate and for use in combination with 5-fluorouracil in various cancers. It is converted into tetrahydrofolate , without requiring metabolism by dihydrofolate reductase. Tetrahydrofolate is an essential enzyme for synthesis of purines and pyrimidine. It allows for some purine/pyrimidine synthesis, diminishing the toxic effects of folic acid antagonist-type chemotherapeutic drugs while still permitting the antitumor activity of the folic acid antagonist through dihydrofolate reductase inhibition.
- [Irobenz 40/100 Liquid Injection](https://admaconcology.com/product/irobenz-40-100-liquid-injection/) - Generic Name- Irinotecan Drug Class- Antineoplastic agent Irinotecan is a DNA topoisomerase I inhibitor which is used as a chemotherapy agent against a variety of solid tumors, such as colorectal, pancreatic, ovarian, and lung cancers. It is also used in combination with other therapeutic agents against colorectal cancer as a first- or second-line treatment. It acts by inhibiting DNA topoisomerase I, an enzyme essential for relaxation of the DNA double helix during replication and transcription. Inhibition of topoisomerase I activity leads to disruption of DNA and RNA synthesis, which ultimately results in cell cycle arrest, apoptosis and cell death.
- [Hydromac 500 capsules](https://admaconcology.com/product/hydromac-500-capsules/) - Generic Name- Hydroxyurea Drug class- Antineoplastic agent Hydroxyurea is an antimetabolite agent, which is used for treatment of resistant leukemia’s and carcinomas of the head and neck. It is also used to increase fetal hemoglobin concentration, thus reducing the necessity for blood transfusions in patients with sickle cell anemia. It acts by inhibiting ribonucleotide diphosphatase reductase and blocking the conversion of ribonucleotides to deoxyribonucleotides, thereby interfering DNA synthesis. Dosage and Administration Individualize dose and treatment based on tumor type, disease state, response to treatment, patient risk factors, and current clinical practice standards Reduce dose by 50% in patients with creatinine clearance less than 60 ml/min2 Dosage Form and Strength Supplied as capsules for oral use Available in 500mg strength
- [Geftibenz 250 Tablets](https://admaconcology.com/product/geftibenz-250-tablets/) - Generic Name- Gefitinib Drug Class- Antineoplastic agent Gefitinib is a selective small-molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (EGFR TKI) used for the treatment of adults with non small cell lung cancer with activating mutations of EGFR tyrosine kinase. It acts by inhibiting EGFR, an enzyme that regulates intracellular signaling pathways essential for the proliferation and survival of cancer cells.
- [Fosamac 150 Lyophilized Injection](https://admaconcology.com/product/fosamac-150-lyophilized-injection/) - Generic Name - Fosaprepitant Drug Class- Antiemetic agent Fosaprepitant is a prodrug formulation of aprepitant, an oral neurokinin-1 (NK1) receptor antagonist. It has been approved by FDA for prevention of acute nausea and vomiting associated with the use of highly and moderately emetogenic chemotherapeutic agents. It decreases the likelihood of vomiting induced by chemotherapeutic agents such as cisplatin by blocking substance P activity at NK1 receptors in the brain. Dosage and Administration Recommended dose for adults: 150 mg on Day 1, as an intravenous infusion over 20 to 30 minutes Recommended dose for pediatrics (6 months to 17 years): Administer a single-day fosaprepitant for injection on Day 1 (for single dose chemotherapy regimens) or a 3- day regimen of fosaprepitant for injection on Day 1 and fosaprepitant capsules or oral suspension on Days 2 and 3 (for single or multi-day chemotherapy regimens). Administer fosaprepitant injection on Day 1 as intravenous infusion over 30 minutes (12-17 years) years to or 60 minutes (6 months to less than 12 years) completing the infusion approximately 30 minutes prior to chemotherapy. However, administer fosaprepitant through a central venous catheter in pediatrics2 Dosage Form and Strength Supplied as a single dose vial containing lyophilized powder for intravenous infusion Available as 150 mg for injection
- [Erlogem 100/150 Tablets](https://admaconcology.com/product/erlogem-100-150-tablets/) - Generic Name- Erlotinib Drug Class- Antineoplastic agent Erlotinib is a tyrosine kinase receptor inhibitor used in the management of some types of non-small cell lung cancer and advanced pancreatic cancer. It acts by selectively and reversibly inhibiting the tyrosine kinase activity of epidermal growth factor receptors which are involved in cancer cell proliferation, apoptosis, angiogenesis, invasions and metastasis.
- [Doxybenz 10/50 Lyophilized Injection](https://admaconcology.com/product/doxybenz-10-50-lyophilized-injection/) - Generic Name - Doxorubicin hydrochloride Drug Class - Antineoplastic agent Doxorubicin is an anthracycline antibiotic, commonly used in the treatment of solid tumors in adult and pediatric patients. It acts by intercalating between DNA base pairs, thereby preventing DNA replication and inhibiting protein synthesis. It also inhibits topoisomerase II, resulting in increased and stabilized cleavable-DNA linked complex during DNA replication. It also produces cytotoxic effects secondary to peroxidation of membrane lipids by forming free radicals
- [Doxybenz 10/50](https://admaconcology.com/product/doxybenz-10-50/) - Generic Name - Doxorubicin hydrochloride Drug Class - Antineoplastic agent Doxorubicin is an anthracycline antibiotic, commonly used in the treatment of solid tumors in adult and pediatric patients. It acts by intercalating between DNA base pairs, thereby preventing DNA replication and inhibiting protein synthesis. It also inhibits topoisomerase II, resulting in increased and stabilized cleavable-DNA linked complex during DNA replication. It also produces cytotoxic effects secondary to peroxidation of membrane lipids by forming free radicals. Dosage and Administration Recommended dose, when used as a single agent: 60 to 75 mg/m2 as a single intravenous injection admin­istered at 21-day intervals. Dose should be reduced in patients with inadequate marrow reserves due to old age, or prior therapy, or neoplastic marrow infiltration Recommended dose, when used in combination with other chemotherapy drugs: 60 mg/m2 given as a single intravenous injection every 21 to 28 days Dosage Form and Strength Supplied as a single use vial containing lyophilized injection for intravenous infusion Available as 10 mg and 50mg for injection
- [Daunamac 20 Lyophilized Injection](https://admaconcology.com/product/daunamac-20-lyophilized-injection/) - Generic Name- Daunorubicin hydrochloride Drug Class- Antineoplastic agent Daunorubicin is an anthracycline antibiotic that has antineoplastic activity and is used in the therapy of acute leukemia and AIDS related Kaposi sarcoma. It acts by intercalating between DNA base pairs and uncoiling the DNA helix, thereby resulting in inhibition of DNA synthesis and apoptosis of rapidly dividing cells.
- [Carbenz 150/450 Liquid Injection](https://admaconcology.com/product/carbenz-150-450-liquid-injection/) - Generic Name- Carboplatin Drug Class- Antineoplastic agent Carboplatin is a second-generation platinum compound which is used in the treatment of patients with ovarian cancer. It has also shown promising results in the treatment of small cell lung cancer, squamous cell carcinomas of the head and neck, and seminomas. It acts by inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links, thereby resulting in apoptosis and cell growth inhibition. Dosage and Administration Recommended dose when used as a single agent in treatment of recurrent ovarian cancer: 360 mg/m2 IV on day 1 every 4 weeks Recommended dose when used in combination with cyclophosphamide in treatment of advanced ovarian cancer: 300 mg/m2 IV on day 1 every 4 weeks for 6 cycles followed by cyclophosphamide 600 mg/m2 IV on day 1 every 4 weeks for 6 cycles Intermittent courses of carboplatin should not be repeated until the neutrophil count is at least 2,000 and the platelet count is at least 100,000 Dosage Form and Strengths Supplied as a single use vial containing aqueous solution for intravenous infusion
- [Calmac 50/150 Tablets](https://admaconcology.com/product/calmac-50-150-tablets/) - Generic Name- Bicalutamide Drug Class- Antineoplastic agent Bicalutamide is a competitive androgen receptor antagonist indicated in several stages of prostate cancer and represents an alternative therapeutic strategy to castration. It acts by blocking the activation of androgen-regulated prostate cell growth and function, leading to cell apoptosis and inhibition of prostate cancer growth Dosage and Administration Recommended dose in combination with an LHRH analog: one 50 mg tablet once daily (morning or evening) Dosage Forms and Strengths Supplied as tablets for oral use Available in 50 mg and 150mg strength
- [Bortlee 2 Lyophilized Injection](https://admaconcology.com/product/bortlee-2-lyophilized-injection/) - Generic Name - Bortezomib Drug Class – Antineoplastic agent Bortezomib is a proteasome inhibitor, approved by FDA for the treatment of refractory multiple myelomas and mantle cell lymphomas. It acts by inhibiting 26-S proteosome complex which regulates protein degradation. Blocking this proteosome complex disrupts various cell signaling pathways leading to cell cycle arrest, inhibition of angiogenesis and apoptosis. It also increases sensitivity of cancer cells to traditional anticancer agents (e.g., gemcitabine, cisplatin, paclitaxel, irinotecan, and radiation). Dosage and Administration Recommended dose in Previously Untreated Multiple Myeloma: 1.3 mg/m2 administered as a 3-5 second bolus intravenous injection in combination with oral melphalan and oral prednisone for nine 6-week treatment cycles Recommended dose in Relapsed Multiple Myeloma and Mantle Cell Lymphoma: 1.3 mg/m2 administered as a 3 to 5 second bolus intravenous injection twice weekly for 2 weeks followed by a 10-day rest period Dose may be adjusted to manage adverse events that occur during treatment Dosage Form and Strength Supplied as a single use sterile lyophilized powder for intravenous infusion
- [Benzpee 100/500 Lyophilized Injection](https://admaconcology.com/product/benzpee-100-500-lyophilized-injection/) - Generic Name – Pemetrexed disodium Drug Class - Antineoplastic agent Pemetrexed is a folate analog inhibitor, approved by FDA for treatment of non small cell lung cancer (NSCLC) and mesothelioma. It acts by inhibiting enzymes involved in folate dependent synthetic pathways such as thymidine synthase. Inhibition of these enzymes may disrupt DNA synthesis and leads to cell death Dosage and Administration Recommended dose for combination use with cisplatin in NSCLC and MPM: 500 mg/m intravenous on Day 1 of each 21-day cycle in combination with cisplatin 75 mg/m intravenous beginning 30 minutes after pemetrexed Recommended dose for single agent use in NSCLC: 500 mg/m intravenous on Day 1 of each 21-day cycle Dose may be reduced based on the toxicities from preceding cycle of therapy Dosage Form and Strength Supplied as single-use sterile lyophilized powder for intraveneous infusion in glass vials Available in 500mg and 100mg for injection
- [Benzol Lyophilized Injection](https://admaconcology.com/product/benzol-lyophilized-injection/) - Generic Name- Zoledronic acid Drug Class – Bisphosphonates Zoledronic acid is a parenteral bisphosphonates, used for treatment of skeletal-related events in patients with bone metastases associated with multiple myeloma or solid tumors. It is the first and only bisphosphonate to demonstrate efficacy in patients with a broad range of tumor types and in multiple myeloma. It acts by inhibiting osteoclast activity and reducing bone resorption and turnover. Dosage and Administration Recommended dose in multiple myeloma and bone metastasis from solid tumors: 4 mg as a single-use intravenous infusion over no less than 15 minutes every 3-4 weeks for patients with creatinine clearance of greater than 60 mL/min Recommended dose in hypercalcemia of malignancy: 4 mg as a single-use intravenous infusion over no less than 15 minutes and 4 mg as retreatment after a minimum of 7 days Dosage Form and Strength Supplied as a single-use vial of concentrate for intravenous infusion Available as 4mg for injection
- [Benzicap 500 Tablets](https://admaconcology.com/product/benzicap-500-tablets/) - Generic Name- Capecitabine Drug Class- Antineoplastic agent Capecitabine is a nucleoside metabolic inhibitor used to treat metastatic and advanced forms of breast and colon cancer, often in combination with other agents. It is selectively activated by tumor cells to its cytotoxic moiety, 5-fluorouracil (5-FU). 5-FU acts by inhibiting nucleic acid synthesis, resulting in disruption of RNA, DNA and protein synthesis.
- [Armocad tablets](https://admaconcology.com/product/armocad-tablets/) - Generic Name: Anastrazole Drug Class- Antineoplastic agent Anastrozole is a third-generation aromatase inhibitor indicated for treatment of postmenopausal women with early and advanced breast cancer. It is also used in the adjuvant setting for the treatment of hormone receptor-positive breast cancer. It acts by reducing the availability of estrogen via inhibition of the aromatase enzyme. Dosage and Administration Recommended dose in breast cancer: 1 mg tablet taken once daily Dosage Form and Strength Supplied as tablets for oral use Available in 1mg strength
- [Admoxel 20/80/120 Liquid Injection](https://admaconcology.com/product/admoxel-20-80-120-liquid-injection/) - Generic Name- Docetaxel Drug Class- Antineoplastic agent Docetaxel is a clinically well-established semi synthetic taxane, with potential anti-mitotic activity. It is widely used for the treatment of breast, prostate and non-small cell lung cancer. It acts by binding to beta tubulin subunit of microtubules, thereby resulting in disassembly of microtubules. Aberrant microtubules induces cell-cycle arrest, apoptosis and ultimately cell death.
- [Admatrone 250 Tablets](https://admaconcology.com/product/admatrone-250-tablets/) - Generic Name- Abiraterone acetate Drug Class- Antineoplastic agentAbiraterone acetate is a new cytochrome P450 (CYP) 17 inhibitor approved by the FDA for use in combination with prednisone for castration resistant prostate cancer. It selectively inhibits androgen biosynthesis by blocking cytochrome P450 c17 (CYP17), a critical enzyme in testosterone synthesis and highly expressed in adrenal glands, testes and within the prostate tumor. Dosage and Administration Recommended dose in prostate cancer: 1,000 mg orally once daily in combination with prednisone 5 mg administered orally twice daily It should be taken on an empty stomach and no food should be consumed for at least two hours before the dose is taken and for at least one hour after the dose is taken 4 Dosage Forms and Strength Supplied as tablets for oral use Available in 250mg strength
- [Admafen 10/20 Tablets](https://admaconcology.com/product/admafen-10-20-tablets-2/) - Generic Name- Tamoxifen citrate Drug Class – Antineoplastic agent Tamoxifen is a nonsteroidal antiestrogen, indicated for the treatment of advanced disease in postmenopausal women and palliative treatment of premenopausal women with estrogen receptor (ER) positive disease. It acts by inhibiting estrogen binding to its receptor, essential for its activity in breast cancer cells. It also leads to an increase in sex hormone binding globulin and decrease in insulin like growth factor 1 and tumor growth α. These changes reduce factors that stimulate tumor growth and induce apoptosis in estrogen receptor positive cells. Dosage and Administration Recommended dose in metastatic breast cancer: 20-40 mg per day, if dose is greater than 20 mg per day then administer in divided doses (morning and evening) Recommended dose for adjuvant treatment of breast cancer, DCIS, reduction of breast cancer incidence in women at high risk: 20 mg per day Dosage Forms and Strengths Supplied as tablets for oral use Available in 10mg and 20mg strength

## Categories

- [Uncategorized](https://admaconcology.com/category/uncategorized/)
- [News](https://admaconcology.com/category/news/)
- [Oncology](https://admaconcology.com/category/oncology/)

## Tags

- [Breast Cancer Myths](https://admaconcology.com/tag/breast-cancer-myths/)
- [Most Common Breast Cancer Myths](https://admaconcology.com/tag/most-common-breast-cancer-myths/)
- [prostate cancer](https://admaconcology.com/tag/prostate-cancer/)
- [myths about prostate cancer](https://admaconcology.com/tag/myths-about-prostate-cancer/)
- [colon cancer](https://admaconcology.com/tag/colon-cancer/)
- [Ovarian caner](https://admaconcology.com/tag/ovarian-caner/)
- [chemotherapy](https://admaconcology.com/tag/chemotherapy/)
- [Benign tumour](https://admaconcology.com/tag/benign-tumour/)
- [malignant tumour](https://admaconcology.com/tag/malignant-tumour/)
- [eye cancer](https://admaconcology.com/tag/eye-cancer/)
- [SKIN CANCER](https://admaconcology.com/tag/skin-cancer/)
- [Neuroendocrine tumors](https://admaconcology.com/tag/neuroendocrine-tumors/)
- [cancer of unknown primary](https://admaconcology.com/tag/cancer-of-unknown-primary/)
- [rare cancers](https://admaconcology.com/tag/rare-cancers/)
- [nutrition in cancer](https://admaconcology.com/tag/nutrition-in-cancer/)
- [Basal cell carcinoma](https://admaconcology.com/tag/basal-cell-carcinoma/)
- [Complementary therapies](https://admaconcology.com/tag/complementary-therapies/)
- [Breast cancer](https://admaconcology.com/tag/breast-cancer/)
- [Cancer prevention](https://admaconcology.com/tag/cancer-prevention/)
- [Bone cancer](https://admaconcology.com/tag/bone-cancer/)
- [mouth sores](https://admaconcology.com/tag/mouth-sores/)
- [Mammography](https://admaconcology.com/tag/mammography/)
- [cancer related depression](https://admaconcology.com/tag/cancer-related-depression/)
- [cancer](https://admaconcology.com/tag/cancer/)
- [oncology](https://admaconcology.com/tag/oncology/)
- [leukemia](https://admaconcology.com/tag/leukemia/)
- [Uterine Cancer](https://admaconcology.com/tag/uterine-cancer/)
- [HPV](https://admaconcology.com/tag/hpv/)
- [tumours](https://admaconcology.com/tag/tumours/)
- [immunotherapy](https://admaconcology.com/tag/immunotherapy/)
- [bladder cancer](https://admaconcology.com/tag/bladder-cancer/)
- [pancreatic cancer](https://admaconcology.com/tag/pancreatic-cancer/)
- [Healthy fats](https://admaconcology.com/tag/healthy-fats/)
- [pleural mesothelioma](https://admaconcology.com/tag/pleural-mesothelioma/)
- [Childhood cancer](https://admaconcology.com/tag/childhood-cancer/)
- [gynaecology](https://admaconcology.com/tag/gynaecology/)
- [women health](https://admaconcology.com/tag/women-health/)

## Product categories

- [Capsules](https://admaconcology.com/product-category/cancer-chemo-capsules/)
- [Liquid Injections](https://admaconcology.com/product-category/oncology-liquid-injections/)
- [Lyophilized Injections](https://admaconcology.com/product-category/cancer-treatment-lypholized-injections/)
- [Tablets](https://admaconcology.com/product-category/oncology-tablets/)